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General Methods: Melting points were determined with a hot-stage apparatus and are 
uncorrected. Optical rotations were measured at the sodium line at ambient temperature 
in CHCl3 solutions. IR spectra were recorded in CCl4 solutions unless otherwise stated. 
NMR spectra were determined at 400 MHz for 1H, 100.6 MHz for 13C in CDCl3 and 
376.5 MHz for 19F in CDCl3 unless otherwise stated, in the presence of TMS as internal 
standard. Mass spectra were determined at 70 eV. Merck silica gel 60 PF (0.063-0.2 
mm) was used for column chromatography. Circular layers of 1 mm of Merck silica gel 
60 PF254 were used on a Chromatotron for centrifugally assisted chromatography. 
Commercially available reagents and solvents were analytical grade or were purified by 
standard procedures prior to use. All reactions involving air- or moisture-sensitive 
materials were carried out under a nitrogen atmosphere. The spray reagents for TLC 
analysis were conducted with 0.5 % vanillin in H2SO4-EtOH (4:1) and further heating 
until development of color. 
General procedure for the synthesis of 2-deoxy-2,2-difluoropyranoses: To a solution 
of the corresponding 2-deoxy-2-fluor-hex-1-enitol (1 mmol) in nitromethane (10 mL) 
and H2O (2 mL) was added F-TEDA-BF4 (SelectfluorTM) (1.5 mmol) and the mixture 
was stirred at room temperature until the disappearance of the starting material was 
observed by TLC (15 h). The reaction mixture was then heated to reflux for 0.5 h, 
poured into brine and extracted with EtOAc. The organic layer was dried and 
concentrated in vacuo. Column chromatography of the residue (hexanes/EtOAc 
mixtures) afforded the required difluorohydrins compounds. 
General procedure for the synthesis of 2-deoxy-2,2-chlorofluoropyranoses: A 
solution of the corresponding 2-deoxy-2-fluor-hex-1-enitol (1 mmol) in THF (20 mL) 
and H2O (10 mL), containing N-chlorosuccinimide (2 mmol) was heated at 50 ºC for 
6-12 h. The reaction mixture was then poured into water and extracted with EtOAc. 
The organic layer was dried and concentrated in vacuo. Column chromatography of the 
residue (hexanes/EtOAc mixtures) afforded the required chlorofluorohydrins 
compounds. 
General procedure for the synthesis of 2-deoxy-2,2-bromofluoropyranoses: A 
solution of the corresponding 2-deoxy-2-fluor-hex-1-enitol (1 mmol) in THF (20 mL) 
and H2O (5 mL), containing freshly crystallized N-bromoacetamide (1.5 mmol) was 
stirred at room temperature for 1-7.5 h. The reaction mixture was then poured into 
water and extracted with EtOAc. The organic layer was dried and concentrated in 
vacuo. Column chromatography of the residue (hexanes/EtOAc mixtures) afforded the 
required bromofluorohydrins compounds. 
General procedure for the synthesis of 2-deoxy-2,2-fluoroiodopyranoses: A solution 
of the corresponding 2-deoxy-2-fluor-hex-1-enitol (1 mmol) in THF (10 mL) and H2O 
(5 mL), containing N-iodosuccinimide (2 mmol) was stirred at room temperature 
(without light exposure) for 1-4 h. The reaction mixture was diluted with EtOAc, 
poured into water and extracted with EtOAc. The organic layer was washed with 
aqueous sodium thiosulfate, dried and concentrated in vacuo. Column chromatography 
of the residue (hexanes/EtOAc mixtures) afforded the required fluoroiodohydrins 
compounds. 
General procedure for the alkoxyl radical fragmentation (ARF) reaction: A 
solution of the dihalohydrins (1 mmol) in CH2Cl2 (50 mL) containing 
(diacetoxyiodo)benzene (1.5 mmol) and iodine (1.5 mmol) was irradiated with two 80 
W tungsten-filament lamps at room temperature. The reaction mixture was then poured 
into water and extracted with CH2Cl2. The organic layer was washed with 10 % aqueous 
sodium thiosulfate, dried and concentrated in vacuo. Column chromatography of the 
residue (hexanes/EtOAc mixtures) afforded the halo-fluoro-iodine compounds. No 
special precautions need to be taken to exclude light during workup and 
chromatography, and these compound can be stored indefinitely under nitrogen at -20 
ºC in the dark. 
3,4-Di-O-acetyl-2,6-dideoxy-2-fluoro-a-L-galactopyranosyl bromide (72S):[1] 
SelecfluorTM (2.7 g, 7.7 mmol, 1.5 equiv) was added to a solution of di-O-acetyl-L-fucal 
(1.1 g, 5.1 mmol, 1 equiv) in dry nitromethane (40 mL) and the reaction was stirred at 
room temperature for 15 h. MgBr2 anhydrous (964 mg, 5.1 mmol, 2 equiv) was then 
added and the reaction was refluxed for 30 minutes. Once cooled, was poured into brine 
and extracted with ethyl acetate. The organic phase was dried over Na2SO4 anhidro and 
concentrated under vacuum. The residue was purified by column chromatography 
(hexanes/EtOAc 8:2) to give 72S (1.2 g, 3.9 mmol, 77 %) as an oil: [a]D = –275.4 (c = 
0.35); 1H NMR: d = 1.22 (d, J = 6.6 Hz, 3H), 2.06 (s, 3H), 2.17 (s, 3H), 4.44 (ddddd, J 
= 0.8, 1.3, 6.6, 6.6, 6.6 Hz, 1H), 4.73 (ddd, J = 4.2, 10.1 Hz, 2J(F,H) = 50.4 Hz, 1H), 
                                               
[1] Numbers ending in S refer to products only cited in the Supporting Information. 
 
5.38 (ddd, J = 1.3, 3.4 Hz, 4J(F,H) = 3.4 Hz, 1H), 5.48 (ddd, J = 3.4, 10.1 Hz, 3J(F,H) = 
10.1 Hz, 1H), 6.60 ppm (dd, J = 0.8, 4.2 Hz, 1H); 13C NMR: d = 15.3 (CH3), 20.4 
(CH3), 20.5 (CH3), 69.2 (d, 2J(F,C) = 17.5 Hz, CH), 69.9 (CH), 70.3 (CH), 84.2 (d, 
1J(F,C) = 194.6 Hz, CH), 87.9 (d, 2J(F,C) = 25.3 Hz, CH), 169.7 (C), 169.9 ppm (C); 
19F NMR: d = –195.7 ppm (dd, 3J(F,H) = 9.2 Hz, 2J(F,H) = 50.5 Hz, 1F); IR: n~ = 2992, 
2942, 1756, 1371, 1235, 1104, 1020 cm–1; MS (70 eV, EI): m/z (%): 313/311 (1) [M–
1]+, 233 (100), 173 (25), 113 (33); HRMS (EI): m/z calcd for C10H1379BrFO5 [M–1]+: 
310.9930, found: 310.9920; elemental analysis calcd (%) for C10H14BrFO5 (313.12): C 
38.36, H 4.51; found: C 38.20, H 4.46. 
3,4-Di-O-acetyl-2-deoxy-2-fluoro-b-L-arabinopyranosyl bromide (73S): 
SelecfluorTM (3.4 g, 9.7 mmol, 1.5 equiv) was added to a solution of di-O-acetyl-L-
arabinal (1.3 g, 6.5 mmol, 1 equiv) in dry nitromethane (65 mL) and the reaction was 
stirred at room temperature for 15 h. MgBr2 anhydrous (1.2 g, 6.5 mmol, 2 equiv) was 
then added and the reaction was refluxed for 30 minutes. Once cooled, was poured into 
brine and extracted with ethyl acetate. The organic phase was dried over Na2SO4 
anhidro and concentrated under vacuum. The residue was purified by column 
chromatography (hexanes/EtOAc 8:2) to give 73S (1.4 g, 4.5 mmol, 70 %) as a 
crystalline solid: m.p. 110.5-112.0 ºC (from n-hexane/EtOAc); [a]D = +393.5 (c = 
0.10); 1H NMR: d = 2.08 (s, 3H), 2.15 (s, 3H), 3.92 (ddd, J = 1.7, 1.7, 13.4 Hz, 1H), 
4.22 (ddd, J = 0.8, 0.8, 13.4 Hz, 1H), 4.78 (ddd, J = 4.2, 9.9 Hz, 2J(F,H) = 50.3 Hz, 1H), 
5.41 (dddd, J = 0.8, 1.7, 3.6 Hz, 4J(F,H) = 3.4 Hz, 1H), 5.47 (ddd, J = 3.6, 9.9 Hz, 
3J(F,H) = 10.0 Hz, 1H), 6.62 ppm (d, J = 4.2 Hz, 1H); 13C NMR (125.7 MHz): d = 20.6 
(CH3), 20.7 (CH3), 64.7 (CH2), 68.3 (CH), 68.6 (d, 2J(F,C) = 17.5 Hz, CH), 84.3 (d, 
1J(F,C) = 194.5 Hz, CH), 88.3 (d, 2J(F,C) = 25.1 Hz, CH), 169.78 (C), 169.84 ppm (C); 
19F NMR: d = –193.8 ppm (dd, 3J(F,H) = 9.2 Hz, 2J(F,H) = 50.4 Hz, 1F); IR: n~ = 1757, 
1371, 1235, 1213, 1091 cm-1; MS (70 eV, EI): m/z (%): 299/297 (16/14) [M-1]+, 219 
(22), 159 (10), 116 (100); HRMS (EI): m/z calcd for C9H1179BrFO5 [M-1]+: 296.9774, 
found: 296.9767; elemental analysis calcd (%) for C9H12BrFO5 (299.09): C 36.14, H 
4.04; found: C 36.10, H 3.84. 
3,4-Di-O-acetyl-2,6-dideoxy-2-fluoro-a-L-glucopyranosyl bromide (74S): Acetic 
anhydride (1 mL) was added to a solution of 1,3,4-tri-O-acetyl-2,6-dideoxy-2-fluoro-L-
glucopyranose (1.0 g, 3.4 mmol, 1 equiv) in 30 % HBr/AcOH (10 mL). The reaction 
was stirred at room temperature for 2 h, then poured into ice/water and extracted with 
ethyl acetate. The organic phase was washed with sodium bicarbonate and brine, dried 
over sodium sulfate and concentrate under vacuum. The residue was purified by column 
chromatography (hexanes/EtOAc 7:3) to give the bromide 74S (979 mg, 3.1 mmol, 92 
%) as a crystalline solid. m.p. 114.7-115.7 ºC (from n-hexane/EtOAc); [a]D = –216.4 (c 
= 0.12); 1H NMR: d = 1.26 (d, J = 6.4 Hz, 3H), 2.07 (s, 3H), 2.08 (s, 3H), 4.20 (ddddd, 
J = 0.8, 6.4, 6.4, 6.4, 10.0 Hz, 1H), 4.50 (ddd, J = 4.2, 9.4 Hz, 2J(F,H) = 49.7 Hz, 1H), 
4.84 (ddd, J = 9.4, 10.0 Hz, 4J(F,H) = 0.5 Hz, 1H), 5.58 (ddd, J = 9.4, 9.4, Hz, 3J(F,H) = 
11.2 Hz, 1H), 6.49 ppm (ddd, J = 0.8, 4.3 Hz, 3J(F,H) = 0.8 Hz, 1H); 13C NMR: d = 
16.8 (CH3), 20.6 (2 ´ CH3), 70.4 (CH), 71.0 (d, 2J(F,C) = 18.3 Hz, CH), 71.9 (CH), 85.8 
(d, 2J(F,C) = 24.6 Hz, CH), 86.7 (d, 1J(F,C) = 201.5 Hz, CH), 169.7 ppm (2 ´ C); 19F 
NMR: d = –188.7 ppm (dd, 3J(F,H) = 9.2 Hz, 2J(F,H) = 45.9 Hz, 1F); IR: n~ = 2942, 
1763, 1238, 1212, 1110, 1043 cm–1; MS (70 eV, EI): m/z (%): 314/312 (<1) [M]+, 
270/268 (3/3), 233 (100), 173 (26), 130 (32), 113 (89); HRMS (EI): m/z calcd for 
C10H1481BrFO5 [M]+: 313.9988, found: 314.0004; elemental analysis calcd (%) for 
C10H14BrFO5 (313.12): C 38.36, H 4.51; found: C 38.46, H 4.50. 
General procedure for the synthesis of vinyl fluorides 5, 10 and 11: TEA (3 mmol) 
was added to a solution of the bromide (1 mmol) in dry acetonitrile (3 mL) and the 
reaction was refluxed for 1.5 h. Once cooled, the reaction was poured into 10 % HCl 
solution and extracted with ethyl acetate. The organic phase was washed with sodium 
bicarbonate, dried over Na2SO4 and concentrated under vacuum. The residue was 
purified by column (hexanes/EtOAc 8:2) to yield the correspondent vinyl fluorides. 
3,4-Di-O-acetyl-2,6-anhydro-1,5-dideoxy-5-fluoro-L-arabino-hex-5-enitol (5): 
Volatile crystalline solid (47 %): m.p. 87.0-88.0 ºC (from n-hexane/EtOAc); [a]D = 
+6.3 (c = 0.22); 1H NMR: d = 1.29 (d, J = 6.6 Hz, 3H), 2.07 (s, 3H), 2.17 (s, 3H), 4.16 
(ddddd, J = 1.3, 1.3, 6.6, 6.6, 6.6 Hz, 1H), 5.30 (ddd, J = 1.3, 5.0 Hz, 4J(F,H) = 5.3 Hz, 
1H), 5.88 (dddd, J = 1.3, 1.3, 5.0 Hz, 3J(F,H) = 1.3 Hz, 1H), 6.74 ppm (dd, J = 1.3 Hz, 
3J(F,H) = 5.0 Hz, 1H); 13C NMR: d = 15.7 (CH3), 20.5 (2 ´ CH3), 63.3 (d, 2J(F,C) = 
20.3 Hz, CH), 66.6 (d, 3J(F,C) = 6.2 Hz, CH), 72.1 (CH), 132.9 (d, 2J(F,C) = 39.7 Hz, 
CH), 142.6 (d, 1J(F,C) = 242.6 Hz, C), 170.1 (C), 170.4 ppm (C); 19F NMR: d = –171.7 
ppm (s, 1F); IR: n~ = 2991, 1755, 1371, 1239, 1215, 1174 cm–1; MS (70 eV, EI): m/z 
(%): 233 (54) [M+1]+, 172 (31), 146 (29), 130 (100), 115 (85); HRMS (EI): m/z calcd 
for C10H14FO5 [M+1]+: 233.0814, found: 233.0825; elemental analysis calcd (%) for 
C10H13FO5 (232.21): C 51.73, H 5.64; found: C 51.93, H 5.60. 
3,4-Di-O-acetyl-1,5-anhydro-2,6-dideoxy-2-fluoro-L-arabino-hex-1-enitol (10): Oil 
(83 %): [a]D = +32.7 (c = 0.74); 1H NMR: d = 1.31 (d, J = 6.9 Hz, 3H), 2.08 (s, 3H), 
2.09 (s, 3H), 4.17 (dddd, J = 5.8, 6.9, 6.9, 6.9 Hz, 1H), 5.02 (ddd, J = 3.4, 5.8 Hz, 
4J(F,H) = 4.2 Hz, 1H), 5.62 (ddd, J = 0.8, 3.4 Hz, 3J(F,H) = 5.0 Hz, 1H), 6.74 ppm (dd, 
J = 0.8 Hz, 3J(F,H) = 5.0 Hz, 1H); 13C NMR: d = 15.6 (CH3), 20.7 (CH3), 20.8 (CH3), 
66.0 (d, 2J(F,C) = 22.5 Hz, CH), 71.8 (d, 3J(F,C) = 8.3 Hz, CH), 72.3 (CH), 132.4 (d, 
2J(F,C) = 39.2 Hz, CH), 142.6 (d, 1J(F,C) = 240.6 Hz, C), 169.5 (C), 170.1 ppm (C); 19F 
NMR: d = –168.3 ppm (s, 1F); IR: n~ = 2986, 2883, 1754, 1369, 1235, 1172, 1039 cm–1; 
MS (70 eV, EI): m/z (%): 233 (17) [M+1]+, 188 (2), 172 (18), 146 (39), 130 (68), 112 
(100); HRMS (EI): m/z calcd for C10H14FO5 [M+1]+: 233.0825, found: 233.0834; 
elemental analysis calcd (%) for C10H13FO5 (232.21): C 51.73, H 5.64. Found: C 51.50, 
H 5.70. 
2,3-Di-O-acetyl-1,5-anhydro-4-deoxy-4-fluoro-D-erythro-pent-4-enitol (11): 
Crystalline solid (47 %): m.p. 44.3-45.6 ºC (from n-hexane/EtOAc); [a]D = –153.9 (c = 
0.35); 1H NMR: d = 2.04 (s, 3H), 2.12 (s, 3H), 3.79 (dd, J = 10.5, 10.5 Hz, 1H), 3.93 
(dd, J = 3.9, 10.5 Hz, 1H), 5.20 (ddd, J = 3.9, 4.3, 10.5 Hz, 1H), 5.82 (ddd, J = 1.2, 4.3 
Hz, 3J(F,H) = 8.1 Hz, 1H), 6.81 ppm (d, 3J(F,H) = 4.1 Hz, 1H); 13C NMR (125.7 MHz): 
d = 20.5 (CH3), 20.7 (CH3), 62.6 (CH2), 63.4 (d, 2J(F,C) = 24.3 Hz, CH), 65.3 (CH), 
134.6 (d, 2J(F,C) = 39.8 Hz, CH), 142.7 (d, 1J(F,C) = 241.9 Hz, C), 169.4 (C), 170.2 
ppm (C); 19F NMR: d = –166.3 ppm (s, 1F); IR: n~ = 2935, 1756 1369, 1233, 1074 cm-1; 
MS (70 eV, EI): m/z (%): 219 (22) [M+1]+, 159 (24), 146 (12), 116 (100); HRMS (EI): 
m/z calcd for C9H12FO5 [M+1]+: 219.0669, found: 219.0666; elemental analysis calcd 
(%) for C9H11FO5 (218.18): C 49.55 H 5.08; found: C 49.33, H 5.14. 
2,6-Anhydro-5-deoxy-5-fluoro-1,3,4-tri-O-methyl-D-arabino-hex-5-enitol (3): A 
suspensión of 1 (1 mmol, 1 equiv) in 3 % MeOH-K2CO3 (5 mL) was stirred at room 
temperature for 1 h. Then, the reaction was neutralized with acid resins Dowex (50 ´ 8). 
The resins were separated by filtration and washed several times with MeOH. The 
filtrate was concentrated under vacuum to yield a white solid which was used without 
futher purifications. To a solution of the triol 2 (1.1 g, 3.8 mmol, 1 equiv) in DMF (15 
mL) was added NaH (60 % suspension oil, 912 mg, 22.8 mmol, 6 equiv) at 0ºC and the 
reaction was stirred for 30 minutes. MeI (1.5 mL, 22.8 mmol, 6 equiv) was added to the 
suspensión and stirred at room temperature for 4 h. The reaction was poured into 
ice/water and extracted with diehyl ether. The organic phase was dried over sodium 
sulfate and concentrated under vacuum. The residue was purified by column 
chromatography (hexanes/EtOAc 90:10) to obtain 3 (532 mg, 2.6 mmol, 68 %) as an 
oil. [a]D = –47.0 (c = 0.46); 1H NMR: d = 3.37 (s, 3H), 3.52 (s, 3H), 3.537 (d, 5J(F,H) = 
1.3 Hz, 3H), 3.54 (dd, J = 3.3, 10.9 Hz, 1H), 3.73 (dd, J = 8.5, 10.9 Hz, 1H), 3.74 (ddd, 
J = 1.1, 5.8 Hz, 3J(F,H) = 4.9 Hz, 1H), 4.15 (ddd, J = 0.8, 5.8 Hz, 4J(F,H) = 4.5 Hz, 
1H), 4.21 (dddd, J = 0.8, 1.1, 3.3, 8.5 Hz, 1H), 6.57 ppm (d, 3J(F,H) = 5.3 Hz, 1H); 13C 
NMR: d = 58.8 (CH3), 59.03 (CH3), 59.05 (CH3), 69.0 (CH2), 71.7 (d, 2J(F,C) = 19.4 
Hz, CH), 74.9 (CH), 75.0 (CH), 130.3 (d, 2J(F,C) = 40.3 Hz, CH), 146.0 ppm (d, 
1J(F,C) = 243.2 Hz, C); 19F NMR: d = –163.6 ppm (s, 1F); IR: n~ = 2971, 2928, 1456, 
1345, 1134, 1149, 1118 cm–1; MS (70 eV, EI): m/z (%): 206 (3) [M]+, 145 (2), 102 (57), 
101 (50), 71 (100); HRMS (EI): m/z calcd for C9H15FO4 [M]+: 206.0954, found: 
206.0958; elemental analysis calcd (%) for C9H15FO4 (206.21): C 52.42, H 7.33; found: 
C 52.50, H 7.02. 
2,6-Anhydro-1,3,4-tri-O-benzyl-5-deoxy-5-fluoro-D-arabino-hex-5-enitol (4): A 
suspensión of 1 (1 mmol, 1 equiv) in 3 % MeOH-K2CO3 (5 mL) was stirred at room 
temperature for 1 h. Then, the reaction was neutralized with acid resins Dowex (50 ´ 8). 
The resins were separated by filtration and washed several times with MeOH. The 
filtrate was concentrated under vacuum to yield a white solid which was used without 
futher purifications. To a solution of the triol 2 (282 mg, 1.72 mmol, 1 equiv) in DMF 
(7 mL) was added NaH (60 % oil suspensión, 413 mg, 10.3 mmol, 6 equiv) at 0 ºC and 
the reaction was stirred for 30 minutes. Benzyl bromide (1.3 mL, 10.3 mmol, 6 equiv) 
was added and the suspensión was stirred at room temperature for 2.5 h. The reaction 
was poured into ice/water and extracted with diehyl ether. The organic phase was dried 
over sodium sulfate and concentrated under vacuum. The residue was purified by 
column chromatography (hexanes/EtOAc 90:10) to obtain 4 (685 mg, 1.2 mmol, 70 %) 
as a crystaline solid: m.p. 62.8-64.1 ºC (from n-hexane/EtOAc); [a]D = -47.3 (c = 
1.35); 1H NMR: d = 3.72 (dd, J = 3.8, 10.9 Hz, 1H), 3.88 (dd, J = 8.0, 10.9 Hz, 1H), 
3.94 (ddd, J = 3.8, 4.1 Hz, 4J(F,H) = 1.7 Hz, 1H), 4.24 (ddd, J = 3.8, 3.8, 8.0 Hz, 1H), 
4.34 (dd, J = 4.1 Hz, 3J(F,H) = 4.8 Hz, 1H), 4.45 (d, J = 11.9 Hz, 1H), 4.53 (d, J = 11.9 
Hz, 1H), 4.58 (d, J = 11.8 Hz, 1H), 4.73 (d, J = 11.9 Hz, 1H), 4.77 (d, J = 11.8 Hz, 1H), 
4.79 (d, J = 11.9 Hz, 1H), 6.60 (d, 3J(F,H) = 5.3 Hz, 1H), 7.26-7.36 ppm (m, 15H); 13C 
NMR: d = 67.1 (CH2), 69.9 (d, 2J(F,C) = 19.5 Hz, CH), 72.5 (d, 3J(F,C) = 8.7 Hz, CH), 
72.7 (CH2), 73.1 (CH2), 73.3 (CH2), 75.7 (CH), 127.6 (4 ´ CH), 127.8 (2 ´ CH), 127.9 
(3 ´ CH), 128.3 (4 ´ CH), 128.4 (2 ´ CH), 130.5 (d, 2J(F,C) = 40.6 Hz, CH), 137.6 (C), 
138.0 (C), 138.1 (C), 146.1 ppm (d, 1J(F,C) = 243.9 Hz, C); 19F NMR: d = –164.4 ppm 
(s, 1F); IR: n~ = 3032, 2868, 1454, 1156, 1102 cm–1; MS (70 eV, EI): m/z (%): 343 (1) 
[M–Bn]+, 253 (4), 220 (4), 163 (14), 91 (100); HRMS (EI): m/z calcd for C20H20FO4 
[M–Bn]+: 343.1346, found: 343.1358; elemental analysis calcd (%) for C27H27FO4 
(434.51): C 74.64, H 6.26; found: C 74.41, H 6.23. 
2,6-Anhydro-5-deoxy-5-fluoro-3,4-O-isopropylidene-D-arabino-hex-5-enitol (6): To 
a solution of 2 (74 mg, 0.45 mmol, 1equiv) in 2,2-dimethoxypropane (1 mL) was added 
CSA (10 mg) and stirred at room temperature for 10 minutes. Water was added to the 
reaction mixture and extracted with ethyl acetate. The organic phase was dried over 
sodium sulfate and concentrated under vacuum. The residue was purified by column 
chomatography (n-hexanes/EtOAc 7:3) to yield 6 (69 mg, 0.34 mmol, 75 %) as a white 
solid: m.p. 77.7–78.4 ºC (from n-hexane/EtOAc); [a]D = –20.9 (c = 0.15); 1H NMR 
(500 MHz): d = 1.41 (s, 3H), 1.52 (s, 3H), 3.86 (dd, J = 4.3, 11.4 Hz, 1H), 3.95 (ddd, J 
= 1.4, 4.3, 6.7 Hz, 1H), 4.02 (dd, J = 6.7, 11.4 Hz, 1H), 4.43 (ddd, J = 1.4, 6.7 Hz, 
4J(F,H) = 5.3 Hz, 1H), 4.85 (dd, J = 6.7 Hz, 3J(F,H) = 1.4 Hz, 1H), 6.67 ppm (d, 3J(F,H) 
= 4.8 Hz, 1H); 13C NMR (125.7 MHz): d = 26.6 (CH3), 27.7 (CH3), 62.3 (CH2), 69.1 (d, 
2J(F,C) = 21.9 Hz, CH), 74.2 (d, 3J(F,C) = 6.0 Hz, CH), 76.1 (CH), 111.9 (C), 131.3 (d, 
2J(F,C) = 41.6 Hz, CH), 147.6 ppm (d, 1J(F,C) = 242.0 Hz, C); 19F NMR: d = –168.1 
ppm (s, 1F); IR: n~ = 3683, 3020, 1521, 1423, 1211, 1175 cm–1; MS (70 eV, EI): m/z 
(%): 204 (21) [M]+, 189 (18), 146 (32), 129 (94), 99 (100); HRMS (EI): m/z calcd for 
C9H13FO4 [M]+: 204.0798, found: 204.0796; elemental analysis calcd (%) for C9H13FO4 
(204.20): C 52.94, H 6.42; found: C 52.92, H 6.51. 
2,6-Anhydro-1-O-benzyl-5-deoxy-5-fluoro-3,4-O-isopropylidene-D-arabino-hex-5-
enitol (7): To a solution of 6 (90 mg, 0.44 mmol, 1equiv) in dry DMF (3 mL) was 
added NaH (60 % oil suspension, 35 mg, 0.88 mmol, 2 equiv) at 0 ºC and the 
suspension was stirred for 30 minutes. When the hydrogen evolution ceased, benzyl 
bromide (0.12 mL, 0.88 mmol, 2 equiv) was added amd the mixture was stirred at room 
temperature for 1 h. MeOH was added to eliminate the excess of NaH, and the resulting 
mixture was poured into ice/water and extracted with diethyl ether. The organic phase 
was dried over sodium sulfate and concentrated under vacuum. The residue was purified 
by column chomatography (hexanes/EtOAc 90:10) to yield 7 (111 mg, 0.38 mmol, 86 
%) as an oil.: [a]D = –46.5 (c = 0.63); 1H NMR: d = 1.39 (s, 3H), 1.49 (s, 3H), 3.74 (dd, 
J = 5.5, 10.1 Hz, 1H), 3.81 (dd, J = 7.2, 10.1 Hz, 1H), 4.02 (ddd, J = 1.3, 5.5, 7.2 Hz, 
1H), 4.42 (ddd, J = 1.3, 6.4 Hz, 4J(F,H) = 5.6 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 4.65 
(d, J = 12.0 Hz, 1H), 4.81 (dd, J = 6.6 Hz, 3J(F,H) = 1.4 Hz, 1H), 6.62 (d, 3J(F,H) = 4.8 
Hz, 1H), 7.29-7.36 ppm (m, 5H); 13C NMR: d = 26.6 (CH3), 27.8 (CH3), 69.03 (d, 
2J(F,C) = 22.0 Hz, CH), 69.04 (CH2), 73.6 (CH2), 74.0 (d, 3J(F,C) = 7.0 Hz, CH), 74.9 
(CH), 111.7 (C), 127.8 (2 ´ CH), 127.9 (CH), 128.5 (2 ´ CH), 131.4 (d, 2J(F,C) = 41.0 
Hz, CH), 137.7 (C), 147.5 ppm (d, 1J(F,C) = 240.0 Hz, C); 19F NMR: d = –168.3 ppm 
(s, 1F); IR: n~ = 2990, 2934, 1454, 1382, 1237, 1177, 1100 cm–1; MS (70 eV, EI): m/z 
(%): 294 (2) [M]+, 279 (37), 236 (2), 203 (29), 130 (18), 107 (99), 91 (100); HRMS 
(EI): m/z calcd for C16H19FO4 [M]+: 294.1267, found: 294.1259; elemental analysis 
calcd (%) for C16H19FO4 (294.32): C 65.29, H 6.51; found: C 65.49, H 6.58. 
2,6-Anhydro-5-deoxy-1-O-(3,5-dinitrobenzoyl)-5-fluoro-3,4-O-isopropylidene-D-
arabino-hex-5-enitol (8): 3,5-Dinitrobenzoyl choride (203 mg, 0.88 mmol, 2 equiv) and 
DMAP (23 mg, 0.19 mmol, 0.2 equiv) were added to a solution of 6 (90 mg, 0.44 
mmol, 1 equiv) in dry piridine (3 mL), and the suspension was stirred at room 
temperature for 1.5 h. The reaction was poured into aqueous HCl and extraced with 
AcOEt, washed with sodium bicarbonate, dried over sodium sulfate and concentrated 
under vacuum. The residue was purified by column chomatography (hexanes/EtOAc 
70:30) to yield 8 (138 mg, 0.35 mmol, 78 %) as a crystalline solid: m.p. 149.5-150.9 ºC 
(from n-hexane/EtOAc); [a]D = –14.4 (c = 0.33); 1H NMR: d = 1.43 (s, 3H), 1.53 (s, 
3H), 4.25 (ddd, J = 1.3, 3.4, 7.7 Hz, 1H), 4.51 (ddd, J = 1.3, 6.9 Hz, 4J(F,H) = 5.0 Hz, 
1H), 4.72 (dd, J = 3.4, 12.2 Hz, 1H), 4.80 (dd, J = 7.7, 12.2 Hz, 1H), 4.91 (dd, J = 6.9 
Hz, 3J(F,H) = 1.8 Hz, 1H), 6.66 (d, 3J(F,H) = 4.8 Hz, 1H), 9.19 (d, J = 2.2 Hz, 2H), 9.25 
ppm (dd, J = 2.2, 2.2 Hz, 1H); 13C NMR: d = 26.7 (CH3), 27.8 (CH3), 65.7 (CH2), 69.1 
(d, 2J(F,C) = 23.1 Hz, CH), 73.5 (CH), 74.1 (d, 3J(F,C) = 7.0 Hz, CH), 112.3 (C), 122.6 
(CH), 129.6 (2 ´ CH), 131.2 (d, 2J(F,C) = 42.2 Hz, CH), 133.4 (C), 147.6 (d, 1J(F,C) = 
244.4 Hz, C), 148.7 (2 ´ C), 162.3 ppm (C); 19F NMR: d = –167.1 ppm (s, 1F); IR: n~ = 
3103, 2959, 1742, 1550, 1343, 1277, 1264, 1163 cm–1; MS (70 eV, EI): m/z (%): 398 
(7) [M]+, 383 (21), 323 (42), 195 (100); HRMS (EI): m/z calcd for C16H15FN2O9 [M]+: 
398.0762, found: 398.0773; elemental analysis calcd (%) for C16H15FN2O9 (398.30): C 
48.25, H 3.80; N, 7.03; found: C 48.54, H 3.72; N, 6.73. 
3,4,6-Tri-O-acetyl-2-deoxy-2,2-difluoro-a-D-lyxo-hexopyranose (12): Oil (43 %); 1H 
NMR (500 MHz): d = 2.06 (s, 3H), 2.10 (s, 3H), 2.15 (s, 3H), 4.16 (d, J = 6.7 Hz, 2H), 
4.56 (ddd, J = 1.2, 6.7, 6.7 Hz, 1H), 5.29 (dd, 3J(F,H) = 3.4, 5.7 Hz, 1H), 5.42-5.50 
ppm (m, 2H); 13C NMR: d = 20.4 (CH3), 20.5 (CH3), 20.6 (CH3), 61.4 (CH2), 65.7 (dd, 
2J(F,C) = 18.3, 18.3 Hz, CH), 66.4 (CH), 67.3 (CH), 91.9 (dd, 2J(F,C) = 27.4, 30.5 Hz, 
CH), 114.2 (dd, 1J(F,C) = 247.2, 253.3 Hz, C), 169.7 (C), 170.5 (C), 170.7 ppm (C); 19F 
NMR: d = –119.9 (dd, 3J(F,H) = 18.4 Hz, 2J(F,F) = 252.4 Hz, 1F), –120.7 ppm (dd, 
3J(F,H) = 13.8 Hz, 2J(F,F) = 252.4 Hz, 1F); IR: n~ = 3612, 1758, 1371, 1235, 1124 cm–1; 
MS (70 eV, EI): m/z (%): 327 (<1) [M+1]+, 309 (4), 267 (2), 223 (8), 206 (17), 178 (20), 
164 (36), 148 (60), 103 (100); HRMS (EI): m/z calcd for C12H17F2O8 [M+1]+: 327.0891, 
found: 327.0883; elemental analysis calcd (%) for C12H16F2O8 (326.25): C 44.18, H 
4.94; found: C 43.91, H 5.09. 
3,4,6-Tri-O-acetyl-2-chloro-2-deoxy-2-fluoro-D-galactopyranose and 3,4,6-tri-O-
acetyl-2-chloro-2-deoxy-2-fluoro-D-talopyranose (13): Oil (70 %), mixture of 
diastereoisomers at C-2 in ratio 3:2; 1H NMR: d = 2.06 (s, 6H), 2.11 (s, 3H), 2.13 (s, 
3H), 2.146 (s, 3H), 2.150 (s, 3H), 4.17 (d, J = 6.7 Hz, 2H), 4.173 (d, J = 6.7 Hz, 2H), 
4.62 (ddd, J = 1.7, 6.7, 6.7 Hz, 2H), 4.94 (d, J = 4.5 Hz, 1H), 4.97 (d, J = 4.8 Hz, 1H), 
5.33-5.48 (m, 5H), 5.66 ppm (dd, J = 4.0 Hz, 3J(F,H) = 9.3 Hz, 1H); 13C NMR: d = 
20.2 (CH3), 20.37 (CH3), 20.42 (2 ´ CH3), 20.5 (2 ´ CH3), 61.4 (2 ´ CH2), 66.0 (CH), 
66.2 (CH), 66.8 (d, 3J(F,C) = 8.6 Hz, CH), 67.4 (CH), 68.0 (d, 2J(F,C) = 21.5 Hz, CH), 
69.0 (d, 2J(F,C) = 16.1 Hz, CH), 94.5 (d, 2J(F,C) = 32.2 Hz, CH), 95.3 (d, 2J(F,C) = 
23.6 Hz, CH), 105.8 (d, 1J(F,C) = 254.6 Hz, C), 107.1 (d, 1J(F,C) = 252.5 Hz, C), 169.6 
(C), 169.7 (C), 170.3 (C), 170.5 (C), 170.6 (C), 171.3 ppm (C); 19F NMR: d = –120.4 (s, 
1F), –125.6 ppm (d, 3J(F,H) = 26.3 Hz, 1F); IR: n~ = 3610, 3431, 2959, 1755, 1371, 
1222, 1079 cm–1; MS (70 eV, EI): m/z (%): 327/325 (4/11) [M–OH]+, 239/237 (3/5), 
196/194 (4/14), 115 (36), 103 (59), 91 (100); HRMS (EI): m/z calcd for C12H1537ClFO7 
[M–OH]+: 327.0461, found: 327.0449; elemental analysis calcd (%) for C12H16ClFO8 
(342.71): C 42.06, H 4.71; found: C 42.22, H 4.99. 
3,4,6-Tri-O-acetyl-2-bromo-2-deoxy-2-fluoro-D-galactopyranose (14): Crystalline 
solid (76 %), anomeric mixture in ratio 4:1 by NMR, only major isomer described: 1H 
NMR (500 MHz): d = 2.05 (s, 3H), 2.11 (s, 3H), 2.15 (s, 3H), 4.16 (dd, J = 1.2, 6.7 Hz, 
2H), 4.61 (ddd, J = 1.9, 6.7, 6.7 Hz, 1H), 5.43 (ddd, J = 1.9, 4.0 Hz, 4J(F,H) = 3.7 Hz, 
1H), 5.56 (dd, J = 4.0 Hz, 3J(F,H) = 10.8 Hz, 1H), 5.64 ppm (s, 1H); 13C NMR (125.7 
MHz): d = 20.5 (CH3), 20.6 (2 ´ CH3), 61.4 (CH2), 66.2 (CH), 66.7 (d, 3J(F,C) = 9.1 
Hz, CH), 68.4 (d, 2J(F,C) = 21.1 Hz, CH), 96.2 (d, 2J(F,C) = 22.2 Hz, CH), 100.6 (d, 
1J(F,C) = 263.7 Hz, C), 169.7 (C), 170.2 (C), 170.7 ppm (C); 19F NMR: d = –119.3 ppm 
(br s, 1F); IR: n~ = 3432, 1755, 1372, 1225, 1079 cm–1; MS (70 eV, EI): m/z (%): 
371/369 (1/1) [M–OH]+, 277 (56), 159 (29), 145 (41), 115 (61), 103 (100); HRMS (EI): 
m/z calcd for C12H1581BrFO7 [M–OH]+: 370.9965, found: 370.9965; elemental analysis 
calcd (%) for C12H16BrFO8 (387.16): C 37.23, H 4.17; found: C 37.56, H 4.17. 
3,4,6-Tri-O-acetyl-2-deoxy-2-fluoro-2-iodo-D-galactopyranose (15): Oil (90 %), 
anomeric mixture in ratio 3:1 by NMR, major isomer: 1H NMR (500 MHz): d = 2.04 (s, 
3H), 2.10 (s, 3H), 2.18 (s, 3H), 4.07-4.18 (d, J = 6.6 Hz, 2H), 4.46 (s, 1H), 4.61 (ddd, J 
= 1.9, 6.6, 6.6, 1H), 5.07 (dd, J = 4.0 Hz, 3J(F,H) = 12.7 Hz, 1H), 5.41-5.49 (m, 1H), 
5.85 ppm (s, 1H); 13C NMR: d = 20.7 (2 ´ CH3), 20.8 (CH3), 61.5 (CH2), 66.0 (CH), 
66.7 (CH), 69.2 (d, 2J(F,C) = 20.3 Hz, CH), 83.3 (d, 1J(F,C) = 263.8 Hz, C), 98.5 (d, 
2J(F,C) = 22.0 Hz, CH), 169.6 (C), 170.2 (C), 170.8 ppm (C); 19F NMR: d = –119.9 
ppm (br s, 1F); minor isomer: 1H NMR (500 MHz): d = 2.12 (s, 3H), 2.16 (s, 3H), 2.17 
(s, 3H), 3.80 (br s, 1H), 4.07–4.18 (m, 3H), 4.90 (dd, J = 4.3 Hz, 3J(F,H) = 13.6 Hz, 
1H), 5.38–5.39 ppm (m, 1H); 13C NMR: d = 20.7 (CH3), 20.8 (2 ´ CH3), 61.2 (CH2), 
66.5 (CH), 72.0 (CH), 72.5 (d, 2J(F,C) = 19.4 Hz, CH), 83.3 (d, 1J(F,C) = 263.8 Hz, C), 
95.7 (d, 2J(FC) = 25.0 Hz, CH), 169.5 (C), 170.0 (C), 170.7 ppm (C); 19F NMR: d = –
118.7 ppm (d, 3J(F,H) = 13.8 Hz, 1F); IR: n~ = 3468, 1755, 1372, 1235, 1074 cm–1; MS 
(70 eV, EI): m/z (%): 417 (6) [M–OH]+, 374 (3), 242 (37), 103 (100); HRMS (EI): m/z 
calcd for C12H16FIO7 [M–OH]+: 416.9847, found: 416.9860; elemental analysis calcd 
(%) for C12H16FIO8 (434.16): C 33.20, H 3.71; found: C 33.20, H 3.80. 
2-Deoxy-2,2-difluoro-3,4,6-tri-O-methyl-a-D-lyxo-hexopyranose (16): Oil (71 %); 1H 
NMR: d = 3.40 (s, 3H), 3.56 (s, 3H), 3.57-3.58 (m, 2H), 3.62 (s, 3H), 3.63-3.73 (m, 
3H), 4.28 (dd, J = 4.2, 7.9 Hz, 1H), 5.21 ppm (d, 3J(F,H) = 7.4 Hz, 1H); 13C NMR: d = 
59.1 (CH3), 60.0 (d, 4J(F,C) = 2.1 Hz, CH3), 61.6 (CH3), 69.3 (CH2), 71.5 (2 ´ CH), 
77.1 (dd, 2J(F,C) = 31.2, 31.2 Hz, CH), 91.9 (dd, 2J(F,C) = 27.9, 37.6 Hz, CH), 116.7 
ppm (dd, 1J(F,C) = 254.6, 250.3 Hz, C); MS (70 eV, EI): m/z (%): 243 (<1) [M+1]+, 222 
(3), 177 (4), 165 (9), 119 (19), 107 (87), 101 (100); HRMS (EI): m/z calcd for 
C9H17F2O5 [M+1]+: 243.1044, found: 243.1055; elemental analysis calcd (%) for 
C9H16F2O5 (242.22): C 44.63, H 6.66; found: C 44.57, H 6.70. 
3,4,6-Tri-O-benzyl-2-deoxy-2,2-difluoro-a-D-lyxo-hexopyranose (17): Oil (47 %); 1H 
NMR (500 MHz): d = 3.40 (dd, J = 5.0, 9.9 Hz, 1H), 3.63 (dd, J = 7.0, 9.9 Hz, 1H), 
3.86 (br s, 1H), 3.96 (ddd, J = 3.8 Hz, 3J(F,H) = 3.8, 22.9 Hz, 1H), 4.21 (ddd, J = 1.4, 
5.0, 7.0 Hz, 1H), 4.41 (d, J = 11.9 Hz, 1H), 4.48 (d, J = 11.9 Hz, 1H), 4.59 (d, J = 11.4 
Hz, 1H), 4.69 (d, J = 11.9 Hz, 1H), 4.92 (d, J = 11.9 Hz, 1H), 4.93 (d, J = 11.4 Hz, 1H), 
5.21 (d, 3J(F,H) = 7.1 Hz, 1H), 7.25-7.39 ppm (m, 15 H); 13C NMR: d = 69.3 (CH2), 
69.8 (CH), 73.5 (CH2), 74.1 (d, 4J(F,C) = 2.1 Hz, CH2), 74.4 (CH2), 74.6 (CH), 74.7 
(dd, 2J(F,C) = 18.7, 23.4 Hz, CH), 91.9 (dd, 2J(F,C) = 27.9, 37.6 Hz, CH), 116.8 (dd, 
1J(F,C) = 252.5, 253.6 Hz, C), 127.7 (CH), 127.8 (2 ´ CH), 127.9 (CH), 128.0 (CH), 
128.1 (2 ´ CH), 128.2 (2 ´ CH), 128.42 (2 ´ CH), 128.45 (2 ´ CH), 128.49 (2 ´ CH), 
137.2 (C), 137.5 (C), 138.0 ppm (C); 19F NMR: d = –117.4 (d, 2J(F,F) = 252.4 Hz, 1F), 
–120.0 ppm (dd, 3J(F,H) = 22.9 Hz, 2J(F,F) = 254.2 Hz, 1F); IR: n~ = 3613, 3400, 3030, 
2928, 2872, 1455, 1154, 1110, 1064 cm–1; MS (70 eV, EI): m/z (%): 379 (5) [M–Bn]+, 
271 (6), 211 (1), 197 (3), 181 (4), 91 (100); HRMS (EI): m/z calcd for C20H21F2O5 [M–
Bn]+: 379.1357, found: 379.1374; elemental analysis calcd (%) for C27H28F2O5 
(470.51): C 68.92, H 6.00; found: C 68.66, H 6.30. 
3,4,6-Tri-O-benzyl-2-bromo-2-deoxy-2-fluoro-D-galactopyranose and 3,4,6-tri-O-
benzyl-2-bromo-2-deoxy-2-fluoro-D-talopyranose (18): Oil (64 %), NMR showed a 
complex mixture of isomers. 19F NMR: d = –113.3 (d, 3J(F,H) = 9.2 Hz, 1F), –121.9 
ppm (d, 3J(F,H) = 27.5 Hz, 1F); IR: n~ = 3608, 3404, 3032, 2872, 1454, 1080 cm-1; MS 
(70 eV, EI): m/z (%): 441/439 (1/1) [M–Bn]+, 359 (1), 253 (1), 181 (4), 91 (100); 
HRMS (EI): m/z calcd for C20H2179BrFO5 [M–Bn]+: 439.0556, found: 439.0541; 
elemental analysis calcd (%) for C27H28BrFO5 (531.42): C 61.02, H 5.31; found: C 
61.09, H 5.60. 
3,4,6-tri-O-benzyl-2-deoxy-2-fluoro-2-iodo-D-galactopyranose (19): Oil (86 %), 
anomeric mixture in ratio 5:1, only major isomer described; 1H NMR: d = 3.47 (dd, J = 
4.3, 10.2 Hz, 1H), 3.61 (dd, J = 3.6 Hz, 3J(F,H) = 11.7 Hz, 1H), 3.69 (dd, J = 7.6, 10.0 
Hz, 1H), 3.91 (m, 1H), 4.14 (br s, 1H), 4.34 (ddd, J = 2.6, 4.3, 7.6 Hz, 1H), 4.40 (d, J = 
11.9 Hz, 1H), 4.50 (d, J = 11.9 Hz, 1H), 4.52 (d, J = 11.7 Hz, 1H), 4.70 (d, J = 11.4 Hz, 
1H), 4.95 (d, J = 11.7 Hz, 1H), 5.00 (d, J = 11.4 Hz, 1H), 5.73 (s, 1H), 7.26-7.44 ppm 
(m, 15 H); 13C NMR: d = 68.8 (CH2), 70.2 (CH), 73.5 (CH2), 73.8 (CH2), 73.9 (CH2), 
74.4 (d, 3J(F,C) = 9.2 Hz, CH), 78.6 (d, 2J(F,C) = 18.3 Hz, CH), 90.4 (d, 1J(F,C) = 
262.4 Hz, C), 97.8 (d, 2J(F,C) = 21.4 Hz, CH), 127.6-128.5 (15 ´ CH), 137.4 (C), 137.7 
(C), 138.1 ppm (C); 19F NMR: d = –114.3 ppm (br s, 1F); IR: n~ = 3615, 3384, 3032, 
2870, 1497, 1454, 1351 cm-1; MS (70 eV, EI): m/z (%): 487 (1) [M–Bn]+, 469 (<1), 359 
(4), 254 (15), 91 (100); HRMS (EI): m/z calcd for C20H21FIO5 [M–Bn]+: 487.0418, 
found: 487.0408; elemental analysis calcd (%) for C27H28FIO5 (578.42): C 56.06, H 
4.88; found: C 56.00, H 4.90. 
3,4-Di-O-acetyl-2,6-dideoxy-2,2-difluoro-b-L-lyxo-hexopyranose (20): Oil (76 %); 
1H NMR (500 MHz): d = 1.18 (d, J = 6.6 Hz, 3H), 2.08 (s, 3H), 2.16 (s, 3H), 4.26 (d, J 
= 3.9 Hz, 1H), 4.50 (dddd, J = 1.6, 6.6, 6.6, 6.6 Hz, 1H), 5.21 (dd, J = 3.9 Hz, 3J(F,H) = 
6.2 Hz, 1H), 5.27 (dd, J = 1.6, 3.9 Hz, 1H), 5.44 ppm (ddd, J = 3.9 Hz, 3J(F,H) = 6.0, 
22.3 Hz, 1H); 13C NMR (125.7 MHz): d = 15.8 (CH3), 20.4 (CH3), 20.5 (CH3), 64.6 
(CH), 66.1 (dd, 2J(F,C) = 19.0, 19.0 Hz, CH), 69.7 (CH), 91.8 (dd, 2J(F,C) = 28.6, 35.3 
Hz, CH), 114.3 (dd, 1J(F,C) = 252.2, 252.2 Hz, C), 169.9 (C), 171.1 ppm (C); 19F NMR: 
d = –120.0 (dd, 3J(F,H) = 24.0 Hz, 2J(F,F) = 252.3 Hz, 1F), –121.9 ppm (d, 2J(F,F) = 
252.3 Hz, 1F); IR: n~ = 3610, 2940, 1753, 1368, 1237, 1117, 1090 cm–1; MS (70 eV, 
EI): m/z (%): 251 (5) [M–OH]+, 233 (5), 209 (4), 163 (24), 148 (95), 135 (81), 130 (60), 
120 (91), 103 (100); HRMS (EI): m/z calcd for C10H13F2O5 [M–OH]+: 251.0731, found: 
251.0729; elemental analysis calcd (%) for C10H14F2O6 (268.21): C 44.78, H 5.26; 
found: C 44.51, H 5.46. 
3,4-Di-O-acetyl-2-chloro-2,6-dideoxy-2-fluoro-L-galactopyranose and 3,4-di-O-
acetyl-2-chloro-2,6-dideoxy-2-fluoro-L-talopyranose (21): Oil (63 %), mixture of two 
isomers at C-2 in 1:1 ratio. 1H NMR (500 MHz): d = 1.19 (d, J = 6.6 Hz, 3H), 1.20 (d, J 
= 6.6 Hz, 3H), 2.10 (s, 3H), 2.12 (s, 3H), 2.159 (s, 3H), 2.161 (s, 3H), 4.02-4.06 (m, 
2H), 4.52-4.58 (m, 2H), 5.24 (dd, J = 1.7, 3.8 Hz, 1H), 5.26 (ddd, J = 1.7, 3.7 Hz, 
4J(F,H) = 3.7 Hz, 1H), 5.34 (dd, J = 4.2 Hz, 3J(F,H) = 6.1 Hz, 1H), 5.41 (d, J = 3.9 Hz, 
1H), 5.44 (dd, J = 3.9 Hz, 3J(F,H) = 26.4 Hz, 1H), 5.65 ppm (dd, J = 4.0 Hz, 3J(F,H) = 
9.6 Hz, 1H); 13C NMR (125.7 MHz): d = 15.6 (CH3), 15.7 (CH3), 20.4 (2 ´ CH3), 20.6 
(2 ´ CH3), 64.6 (CH), 64.8 (CH), 68.5 (d, 2J(F,C) = 21.4 Hz, CH), 69.5 (d, 2J(F,C) = 
15.8 Hz, CH), 69.7 (d, 4J(F,C) = 7.8 Hz, CH), 70.1 (CH), 94.6 (d, 2J(F,C) = 32.6 Hz, 
CH), 95.5 (d, 2J(F,C) = 23.4 Hz, CH), 105.9 (d, 1J(F,C) = 253.8 Hz, C), 107.2 (d, 
1J(F,C) = 252.0 Hz, C), 169.7 (C), 169.8 (C), 170.8 (C), 171.0 ppm (C); 19F NMR: d = –
120.6 (d, 3J(F,H) = 9.1 Hz, 1F), –125.1 ppm (d, 3J(F,H) = 27.5 Hz, 1F); IR: n~ = 3613, 
2958, 2872, 1753, 1369, 1237, 1216, 1079 cm–1; MS (70 eV, EI): m/z (%): 269/267 
(2/7) [M–OH]+, 219 (10), 189 (21), 152 (100), 136 (87); HRMS (EI): m/z calcd for 
C10H1335ClFO5 [M–OH]+: 267.0436, found: 267.0448; elemental analysis calcd (%) for 
C10H14ClFO6 (284.67): C 42.19, H 4.97; found: C 42.19, H 4.97.  
3,4-Di-O-acetyl-2-bromo-2,6-dideoxy-2-fluoro-L-galactopyranose (22): Oil (82 %), 
anomeric mixture in ratio 4:1 by NMR, only major described; 1H NMR: d = 1.18 (d, J = 
6.4 Hz, 3H), 2.11 (s, 3H), 2.18 (s, 3H), 4.14 (d, J = 3.0 Hz, 1H), 4.54 (dddd, J = 1.8, 6.4, 
6.4, 6.4 Hz, 1H), 5.25 (ddd, J = 1.8, 4.2 Hz, 4J(F,H) = 3.7 Hz, 1H), 5.53 (dd, J = 4.2 Hz, 
3J(F,H) = 11.1 Hz, 1H), 5.58 ppm (dd, J = 3.0 Hz, 1H); 13C NMR: d = 15.5 (CH3), 20.5 
(CH3), 20.6 (CH3), 64.4 (CH), 68.9 (d, 2J(F,C) = 20.4 Hz, CH), 69.5 (d, 3J(F,C) = 7.5 
Hz, CH), 96.3 (d, 2J(F,C) = 22.6 Hz, CH), 100.9 (d, 1J(F,C) = 263.2 Hz, C), 169.8 (C), 
170.7 ppm (C); 19F NMR: d = –118.4 ppm (d, 3J(F,H) = 9.1 Hz, 1F); IR: n~ = 3612, 
3470, 2990, 2941, 1752, 1368, 1236, 1162, 1083 cm–1; MS (70 eV, EI): m/z (%): 
313/311 (2/2) [M–OH]+, 270/268 (2/2), 255/253 (2/2), 243/241 (4/4), 211 (3), 182/180 
(57/57), 153/151 (52/52), 99 (100); HRMS (EI): m/z calcd for C10H1381BrFO5 [M–OH]+: 
312.9910, found: 312.9900; elemental analysis calcd (%) for C10H14BrFO6 (329.12): C 
36.49, H 4.29; found: C 36.56, H 4.52.  
3,4-Di-O-acetyl-2,6-dideoxy-2-fluoro-2-iodo-L-galactopyranose (23): Oil (86 %), 
anomeric mixture in ratio 2:1; 1H NMR: d = 1.20 (d, J = 6.6 Hz, 3H), 1.24 (d, J = 6.5 
Hz, 3H), 2.12 (s, 3H), 2.14 (s, 3H), 2.22 (s, 3H), 2.26 (s, 3H), 3.21 (d, J = 2.6 Hz, 1H), 
3.48 (d, J = 11.4 Hz, 1H), 3.70 (dd, J = 11.4 Hz, 3J(F,H) = 3.6 Hz, 1H), 3.98 (dddd, J = 
1.4, 6.5, 6.5, 6.5 Hz, 1H), 4.57 (dddd, J = 1.8, 6.6, 6.6, 6.6 Hz, 1H), 4.91 (dd, J = 4.0 
Hz, 3J(F,H) = 13.7 Hz, 1H), 5.09 (dd, J = 4.0 Hz, 3J(F,H) = 13.0 Hz, 1H), 5.26 (ddd, J = 
1.4, 4.0 Hz, 4J(F,H) = 2.5 Hz, 1H), 5.32 (ddd, J = 1.8, 4.0 Hz, 4J(F,H) = 3.0 Hz, 1H), 
5.84 ppm (d, J = 2.6 Hz, 1H); 13C NMR: d = 15.5 (CH3), 15.6 (CH3), 20.6 (CH3), 20.7 
(2 ´ CH3), 20.8 (CH3), 64.3 (CH), 69.4 (CH), 69.5 (CH), 69.6 (d, 2J(F,C) = 20.3 Hz, 
CH), 70.7 (CH), 72.8 (d, 2J(F,C) = 19.2 Hz, CH), 83.9 (d, 1J(F,C) = 262.0 Hz, 2 ´ C), 
95.6 (d, 2J(F,C) = 24.7 Hz, CH), 98.7 (d, 2J(F,C) = 21.2 Hz, CH), 169.6 (C), 169.7 (C), 
170.6 ppm (2 ´ C); 19F NMR: d = -118.5 (d, 3J(F,H) = 13.5 Hz, 1F), -119.6 ppm (br s, 
1F); IR: n~ = 3611, 3523, 2939, 1752, 1372, 1233, 1084 cm–1; MS (70 eV, EI): m/z (%): 
376 (1) [M]+, 316 (43), 254 (18), 243 (55), 228 (64), 199 (94), 189 (76), 127 (100); 
HRMS (EI): m/z calcd for C10H14FIO6 [M]+: 375.9819, found: 375.9813; elemental 
analysis calcd (%) for C10H14FIO6 (376.12): C 31.93, H 3.75; found: C 31.81, H 3.74. 
6-O-Benzyl-2-bromo-2-deoxy-2-fluoro-3,4-O-isopropylidene-D-galactopyranose 
(24): Oil (55 %), anomeric mixture in ratio 8:1, only major isomer described. 1H NMR 
(500 MHz): d = 1.33 (s, 3H), 1.53 (s, 3H), 3.67 (dd, J = 2.9, 10.4 Hz, 1H), 3.79 (dd, J = 
8.8, 10.4 Hz, 1H), 4.09 (dd, J = 3.0, 5.8 Hz, 1H), 4.52 (d, J = 12.2 Hz, 1H), 4.59 (ddd, J 
= 2.9, 3.0, 8.8 Hz, 1H), 4.61 (dd, J = 5.8 Hz, 3J(F,H) = 19.8 Hz,  1H), 4.73 (d, J = 12.2 
Hz, 1H), 5.25 (d, J = 4.8 Hz, 1H), 5.46 (dd, J = 4.8 Hz, 3J(F,H) = 4.8 Hz, 1H), 
7.30-7.37 ppm (m, 5H); 13C NMR (125.7 MHz): d = 25.6 (CH3), 25.7 (CH3), 66.0 
(CH), 69.2 (CH2), 73.4 (CH), 73.7 (CH2), 77.2 (d, 2J(F,C) = 15.2 Hz, CH), 94.6 (d, 
2J(F,C) = 31.5 Hz, CH), 103.0 (d, 1J(F,C) = 258.7 Hz, C), 110.7 (C), 128.1 (2 ´ CH), 
128.3 (CH), 128.5 (2 ´ CH), 137.0 ppm (C); 19F NMR: d = –118.6 ppm (d, 3J(F,H) = 
22.9 Hz, 1F); IR: n~ = 3355, 2938, 1455, 1383, 1220, 1149, 1096 cm–1; MS (70 eV, EI): 
m/z (%): 392/390 (1/1) [M]+, 377/375 (3/3), 235 (9), 91 (100); HRMS (EI): m/z calcd 
for C16H2081BrFO5 [M]+: 392.0458, found: 392.0471; elemental analysis calcd (%) for 
C16H20BrFO5 (391.23): C 49.12, H 5.15; found: C 49.22, H 5.19. 
6-O-Benzyl-2-deoxy-2-fluoro-3,4-O-isopropylidene-2-iodo-D-galactopyranose (25): 
Crystalline solid (79 %), anomeric mixture in ratio 10:1, only major isomer described. 
1H NMR (500 MHz): d = 1.34 (s, 3H), 1.54 (s, 3H), 3.66 (dd, J = 2.9, 10.3 Hz, 1H), 
3.80 (dd, J = 9.0, 10.3 Hz, 1H), 3.98 (dd, J = 3.0, 5.6 Hz, 1H), 4.52 (d, J = 12.3 Hz, 
1H), 4.61 (ddd, J = 2.9, 3.0, 9.0 Hz, 1H), 4.72 (dd, J = 5.6 Hz, 3J(F,H) = 22.3 Hz, 1H), 
4.78 (d, J = 12.3 Hz, 1H), 5.28 (d, J = 4.5 Hz, 1H), 5.58 (dd, J = 4.5, 3J(F,H) = 4.3 Hz, 
1H), 7.30-7.39 ppm (m, 5H); 13C NMR (125.7 MHz): d = 25.5 (CH3), 25.8 (CH3), 65.7 
(CH), 69.3 (CH2), 73.3 (CH), 73.7 (CH2), 79.4 (d, 2J(F,C) = 14.7 Hz, CH), 88.2 (d, 
1J(F,C) = 260.7 Hz, C), 96.2 (d, 2J(F,C) = 28.9 Hz, CH), 110.4 (C), 127.9 (CH), 128.3 
(2 ´ CH), 128.5 (2 ´ CH), 137.0 ppm (C); 19F NMR: d = –119.0 ppm (d, 3J(F,H) = 22.9 
Hz, 1F); IR: n~ = 3356, 3018, 1550, 1214, 1094 cm–1; MS (70 eV, EI): m/z (%): 438 (2) 
[M]+, 423 (4), 380 (1), 332 (2), 253 (4), 235 (5), 189 (2), 149 (3), 107 (78), 91 (100); 
HRMS (EI): m/z calcd for C16H20FIO5 [M]+: 438.0340, found: 438.0347; elemental 
analysis calcd (%) for C16H20FIO5 (438.23): C 43.85, H 4.60; found: C 43.96, H 4.61. 
2-Chloro-2-deoxy-6-O-(3,5-dinitrobenzoyl)-2-fluoro-3,4-O-isopropylidene-a-D-
galactopyranose (26): Oil (40 %); 1H NMR: d = 1.43 (s, 3H), 1.58 (s, 3H), 3.56 (d, J = 
5.0 Hz, 1H), 4.41 (ddd, J = 1.2, 2.7, 5.8 Hz, 1H), 4.64 (d, J = 5.8 Hz, 3J(F,H) = 17.5 Hz, 
1H), 4.70-4.78 (m, 3H), 5.38 (dd, J = 5.0 Hz, 3J(F,H) = 5.8 Hz, 1H), 9.17 (d, J = 2.1 
Hz, 2H), 9.23 ppm (dd, J = 2.1, 2.1 Hz, 1H); 13C NMR: d = 25.6 (CH3), 25.7 (CH3), 
65.3 (CH), 65.6 (CH2), 73.0 (CH), 76.2 (d, 2J(F,C) = 17.2 Hz, CH), 93.7 (d, 2J(F,C) = 
33.3 Hz, CH), 106.2 (d, 1J(F,C) = 251.4 Hz, C), 111.4 (C), 122.6 (CH), 129.5 (2 ´ CH), 
133.5 (C), 148.7 (2 ´ C), 162.4 ppm (C); 19F NMR: d = –121.1 ppm (d, 3J(F,H) = 18.4 
Hz, 1F); IR: n~ = 3610, 3455, 3102, 2958, 1740, 1549, 1343, 1266, 1154 cm–1; MS (70 
eV, EI): m/z (%): 437/435 (10/29) [M–CH3]+, 399 (45), 385 (17), 195 (100), 149 (29); 
HRMS (EI): m/z calcd for C15H13ClFN2O10 [M–CH3]+: 435.0243, found: 435.0220; 
elemental analysis calcd (%) for C16H16ClFN2O10 (450.76): C 42.63, H 3.58; N, 6.21; 
found: C 42.46, H 3.53; N, 6.47. 
2-Bromo-2-deoxy-6-O-(3,5-dinitrobenzoyl)-2-fluoro-3,4-O-isopropylidene-a-D-
galactopyranose (27): Oil (67 %); 1H NMR (500 MHz, CD3OD): d = 1.40 (s, 3H), 1.50 
(s, 3H), 4.45 (dd, J = 3.0, 5.6 Hz, 1H), 4.65 (d, J = 6.0 Hz, 2H), 4.78-7.82 (m, 2H), 5.28 
(d, 3J(F,H) = 4.6 Hz, 1H), 9.09 (d, J = 2.0 Hz, 2H), 9.19 ppm (dd, J = 2.0, 2.0 Hz, 1H); 
13C NMR (125.7 MHz, CD3OD): d = 26.0 (2 ´ CH3), 65.7 (CH), 66.3 (CH2), 74.9 (d, 
3J(F,C) = 6.1 Hz, CH), 78.7 (d, 2J(F,C) = 15.3 Hz, CH), 96.0 (d, 2J(F,C) = 30.5 Hz, 
CH), 104.7 (d, 1J(F,C) = 259.4 Hz, C), 111.6 (C), 123.6 (CH), 130.1 (2 ´ CH), 134.7 
(C), 150.2 (2 ´ C), 164.0 ppm (C); 19F NMR: d = –119.3 ppm (d, 3J(F,H) = 18.4 Hz, 
1F); IR: n~ = 3610, 3405, 3098, 2950, 1741, 1550, 1342, 1280, 1152 cm–1; MS (70 eV, 
EI): m/z (%): 481/479 (13/10) [M–CH3]+, 399 (70), 385 (29), 195 (100); HRMS (EI): 
m/z calcd for C15H1379BrF N2O10 [M–CH3]+: 478.9738, found: 478.9737; elemental 
analysis calcd (%) for C16H16BrFN2O10 (495.21): C 38.81, H 3.26; N, 5.66; found: C 
38.56, H 3.22; N, 5.42. 
3,4,6-Tri-O-acetyl-2-deoxy-2,2-difluoro-a-D-arabino-hexopyranose (28): Crystalline 
solid (67 %); 1H NMR: d = 2.05 (s, 3H), 2.10 (s, 3H), 2.13 (s, 3H), 3.88 (d, J = 4.5 Hz, 
1H), 4.19 (dd, J = 2.6, 12.4 Hz, 1H), 4.24 (dd, J = 4.3, 12.4 Hz, 1H), 4.32 (ddd, J = 2.6, 
4.3, 10.3 Hz, 1H), 5.23 (ddd, J = 9.8, 10.3 Hz, 4J(F,H) = 1.0 Hz, 1H), 5.27 (dd, J = 4.5 
Hz, 3J(F,H) = 5.0 Hz, 1H), 5.61 ppm (ddd, J = 9.8 Hz, 3J(F,H) = 4.8, 20.4 Hz, 1H); 13C 
NMR: d = 20.3 (CH3), 20.4 (CH3), 20.6 (CH3), 61.8 (CH2), 67.6 (d, 3J(F,C) = 6.6 Hz, 
CH), 67.8 (CH), 68.7 (dd, 2J(F,C) = 18.5, 21.0 Hz, CH), 91.2 (dd, 2J(F,C) = 28.5, 35.6 
Hz, CH), 115.5 (dd, 1J(F,C) = 245.3, 257.7 Hz, C), 169.5 (C), 169.9 (C), 171.1 ppm (C); 
19F NMR: d = –120.9 (d, 2J(F,F) = 252.4 Hz, 1F), –122.5 ppm (dd, 3J(F,H) = 18.3 Hz, 
2J(F,F) = 252.3 Hz, 1F); IR: n~ = 3606, 2955, 1764, 1369, 1224 cm–1; MS (70 eV, EI): 
m/z (%): 309 (3) [M–OH]+, 291 (1), 206 (17), 164 (33), 145 (62), 103 (100); HRMS 
(EI): m/z calcd for C12H15F2O7 [M–OH]+: 309.0786, found: 309.0786; elemental 
analysis calcd (%) for C12H16F2O8 (326.25): C 44.18, H 4.94; found: C 44.08, H 5.06. 
3,4,6-Tri-O-acetyl-2-chloro-2-deoxy-2-fluoro-D-glucopyranose and 3,4,6-tri-O-
acetyl-2-chloro-2-deoxy-2-fluoro-D-mannopyranose (29): Oil (65 %), 
diastereoisomeric mixture at C-2 in ratio 3:1, only major isomer described. 1H NMR 
(500 MHz): d = 2.04 (s, 3H), 2.09 (s, 3H), 2.13 (s, 3H), 4.18 (d, J = 3.4 Hz, 2H), 4.32 
(ddd, J = 3.4, 3.4, 10.1 Hz, 1H), 4.86 (d, J = 4.2 Hz, 1H), 5.20 (dd, J = 9.3, 10.1 Hz, 
1H), 5.38 (d, J = 4.0 Hz, 1H), 5.78 ppm (dd, J = 9.3 Hz, 3J(F,H) = 7.9 Hz, 1H); 13C 
NMR (125 MHz): d = 20.4 (2 ´ CH3), 20.6 (CH3), 61.8 (CH2), 67.9 (d, 3J(F,C) = 5.1 
Hz, CH), 68.2 (CH), 70.6 (d, 2J(F,C) = 21.3 Hz, CH), 94.4 (d, 2J(F,C) = 24.3 Hz, CH), 
108.4 (d, 1J(F,C) = 259.8 Hz, C), 169.5 (C), 169.9 (C), 171.0 ppm (C); 19F NMR: d = –
122.0 ppm (s, 1F); IR: n~ = 3606, 3471, 2957, 1762, 1370, 1221, 1068, 1048 cm–1; MS 
(70 eV, EI): m/z (%): 327/325 (3/9) [M–OH]+, 211/209 (5/11), 196/194 (7/20), 153/151 
(12/38), 145 (54), 103 (100); HRMS (EI): m/z calcd for C12H1537ClFO7 [M–OH]+: 
327.0461, found: 327.0460; elemental analysis calcd (%) for C12H16ClFO8 (342.71): C 
42.06, H 4.71; found: C 42.05, H 5.04. 
3,4,6-Tri-O-acetyl-2-bromo-2-deoxy-2-fluoro-D-glucopyranose (30): Oil (72 %), 
anomeric mixture in ratio 8:1, only major isomer described. 1H NMR (500 MHz): d = 
2.04 (s, 3H), 2.09 (s, 3H), 2.13 (s, 3H), 4.15 (dd, J = 4.2, 12.4 Hz, 1H), 4.19 (dd, J = 
2.6, 12.4 Hz, 1H), 4.31 (ddd, J = 2.6, 4.2, 10.0 Hz, 1H), 4.67 (br s, 1H), 5.22 (dd, J = 
9.5, 10.0 Hz, 1H), 5.54 (s, 1H), 5.61 ppm (dd, J = 9.5 Hz, 3J(F,H) = 9.5 Hz, 1H); 13C 
NMR (125.7 MHz): d = 20.5 (CH3), 20.6 (CH3), 20.7 (CH3), 61.8 (CH2), 68.2 (d, 
3J(F,C) = 5.3 Hz, CH), 68.4 (CH), 70.9 (d, 3J(F,C) = 19.4 Hz, CH), 95.1 (d, 2J(F,C) = 
23.2 Hz, CH), 104.4 (d, 1J(F,C) = 263.7 Hz, C), 169.5 (C), 169.9 (C), 171.1 ppm (C); 
19F NMR: d = –120.1 ppm (d, 3J(F,H) = 8.8 Hz, 1F); IR: n~ = 3607, 3449, 1764, 1221, 
1047 cm–1; MS (70 eV, EI): m/z (%): 371/369 (14/14) [M–OH]+, 329/327 (2/2), 277 
(23), 240/238 (14/14), 197/195 (18/18), 159 (30), 145 (60), 103 (100); HRMS (EI): m/z 
calcd for C12H1581BrFO7 [M–OH]+: 370.9965, found: 370.9967; elemental analysis 
calcd (%) for C12H16BrFO8 (387.16): C 37.23, H 4.17; found: C 37.14, H 4.25. 
3,4,6-Tri-O-acetyl-2-deoxy-2-fluoro-2-iodo-D-glucopyranose (31): Oil (84 %), 
anomeric mixture in ratio 3:1, major isomer: 1H NMR: d = 2.05 (s, 3H), 2.12 (s, 3H), 
2.15 (s, 3H), 3.63 (s, 1H), 4.15 (dd, J = 4.5, 12.4 Hz, 1H), 4.21 (dd, J = 2.6, 12.4 Hz, 
1H), 4.33 (ddd, J = 2.6, 4.5, 10.1 Hz, 1H), 5.00 (dd, J = 9.3 Hz, 3J(F,H) = 11.1 Hz, 1H), 
5.23 (dd, J = 9.3, 10.1 Hz, 1H), 5.76 ppm (br s, 1H); 13C NMR: d = 20.5 (CH3), 20.67 
(CH3), 20.69 (CH3), 61.7 (CH2), 68.3 (CH), 69.0 (d, 3J(F,C) = 5.4 Hz, CH), 71.8 (d, 
2J(F,C) = 19.4 Hz, CH), 90.0 (d, 1J(F,C) = 270.8 Hz, C), 97.0 (d, 2J(F,C) = 21.5 Hz, 
CH), 169.5 (C), 169.7 (C), 171.0 ppm (C); 19F NMR: d = –119.9 ppm (d, 3J(F,H) = 9.2 
Hz, 1F); minor isomer: 1H NMR: d = 2.05 (s, 3H), 2.10 (s, 3H), 2.17 (s, 3H), 3.55 (d, J 
= 11.1 Hz, 1H), 3.74 (dd, J = 11.1 Hz, 3J(F,H) = 2.4 Hz, 1H), 3.83 (ddd, J = 3.7, 3.7, 
10.1 Hz, 1H), 4.18 (d, J = 3.7 Hz, 2H), 4.85 (dd, J = 9.5 Hz, 3J(F,H) = 10.4 Hz, 1H), 
5.19 ppm (dd, J = 9.5, 10.1 Hz, 1H); 13C NMR: d = 20.4 (CH3), 20.60 (CH3), 20.63 
(CH3), 61.7 (CH2), 68.9 (d, 3J(F,H) = 5.4 Hz, CH), 72.8 (CH), 74.3 (d, 2J(F,C) = 19.3 
Hz, CH), 90.0 (d, 1J(F,C) = 270.8 Hz, C), 94.6 (d, 2J(F,C) = 23.6 Hz, CH), 169.3 (C), 
169.5 (C), 170.9 ppm (C); 19F NMR: d = –119.6 ppm (d, 3J(F,H) = 9.2 Hz, 1F); IR: n~ = 
3607, 3469, 2956, 1758, 1372, 1223, 1050 cm–1; MS (70 eV, EI): m/z (%): 417 (4) [M–
OH]+, 374 (5), 307 (5), 287 (72), 277 (30), 247 (67), 115 (100); HRMS (EI): m/z calcd 
for C12H15FIO7 [M–OH]+: 416.9846, found: 416.9832; elemental analysis calcd (%) for 
C12H16FIO8 (434.16): C 33.20, H 3.71; found: C 33.36, H 3.77. 
3,4-Di-O-acetyl-2,6-dideoxy-2,2-difluoro-b-L-arabino-hexopyranose (32): Oil (76 
%); 1H NMR (500 MHz): d = 1.21 (d, J = 6.3 Hz, 3H), 2.04 (s, 3H), 2.12 (s, 3H), 3.92 
(br s, 1H), 4.20 (dddd, J = 6.3, 6.3, 6.3, 9.9 Hz, 1H), 4.94 (ddd, J = 9.9, 9.9 Hz, 3J(F,H) 
= 1.3 Hz, 1H), 5.16 (dd, 3J(F,H) = 3.7, 5.0 Hz, 1H), 5.55 ppm (ddd, J = 9.9 Hz, 3J(F,H) 
= 4.6, 20.6 Hz, 1H); 13C NMR: d = 17.0 (CH3), 20.5 (CH3), 20.6 (CH3), 65.9 (CH), 68.7 
(dd, 2J(F,C) = 19.0, 19.4 Hz, CH), 72.6 (dd, 3J(F,C) = 5.8, 8.5 Hz, CH), 91.2 (dd, 
2J(F,C) = 35.4, 36.5 Hz, CH), 115.8 (dd, 1J(F,C) = 244.5, 257.8 Hz, C), 168.8 (C), 170.1 
ppm (C); 19F NMR: d = –120.8 (d, 2J(F,F) = 252.0 Hz, 1F), –122.3 ppm (dd, 3J(F,H) = 
23.0 Hz, 2J(F,F) = 252.0 Hz, 1F); IR: n~ = 3615, 3472, 2964, 1764, 1376, 1233, 1078 
cm–1; MS (70 eV, EI): m/z (%): 269 (<1) [M+1]+, 251 (8), 181 (11), 164 (11), 135 (69), 
148 (44), 103 (100); HRMS (EI): m/z calcd for C10H15F2O6 [M+1]+: 269.0837, found: 
269.0848; elemental analysis calcd (%) for C10H14F2O6 (268.21): C 44.78, H 5.26; 
found: C 44.80, H 5.17. 
3,4-Di-O-acetyl-2-chloro-2,6-dideoxy-2-fluoro-L-glucopyranose and 3,4-di-O-
acetyl-2-chloro-2,6-dideoxy-2-fluoro-L-mannopyranose (33): Crystalline solid (75 
%), mixture of two diastereoisomers at C-2 in ratio 2:1; 1H NMR: d = 1.22 (d, J = 6.4 
Hz, 6H), 2.05 (s, 3H), 2.06 (s, 3H), 2.14 (s, 3H), 2.16 (s, 3H), 3.75 (d, J = 3.7 Hz, 1H), 
3.82 (d, J = 3.2 Hz, 1H), 4.20-4.27 (m, 2H), 4.95 (dd, J = 9.8, 9.8 Hz, 1H), 4.99 (ddd, J 
= 9.8, 9.8 Hz, 4J(F,H) = 1.6 Hz, 1H), 5.28 (dd, J = 3.7 Hz, 3J(F,H) = 3.7 Hz, 1H), 5.34 
(d, J = 3.2 Hz, 1H), 5.57 (dd, J = 9.8 Hz, 3J(F,H) = 23.4 Hz, 1H), 5.75 ppm (dd, J = 9.8 
Hz, 3J(F,H) = 8.2 Hz, 1H); 13C NMR: d = 17.1 (CH3), 17.2 (CH3), 20.4 (2 ´ CH3), 20.6 
(2 ´ CH3), 66.1 (CH), 66.4 (CH), 70.6 (d, 2J(F,C) = 21.4 Hz, CH), 72.0 (d, 2J(F,C) = 
18.3 Hz, CH), 72.5 (CH), 72.8 (d, 3J(F,C) = 6.1 Hz, CH), 94.0 (d, 2J(F,C) = 30.5 Hz, 
CH), 94.5 (d, 2J(F,C) = 24.4 Hz, CH), 107.9 (d, 1J(F,C) = 247.2 Hz, C), 108.9 (d, 
1J(F,C) = 259.4 Hz, C), 169.7 (2 ´ C), 169.9 ppm (2 ´ C); 19F NMR: d = –121.8 (s, 1F), 
–127.4 ppm (d, 3J(F,H) = 22.9 Hz, 1F); IR: n~ = 3612, 3486, 2987, 1764, 1374, 1233, 
1213, 1061 cm–1; MS (70 eV, EI): m/z (%): 269/267 (8/23) [M–OH]+, 189 (26), 154/152 
(33/100), 136 (86), 103 (51); HRMS (EI): m/z calcd for C10H1335ClFO5 [M–OH]+: 
267.0436, found: 267.0440; elemental analysis calcd (%) for C10H14ClFO6 (284.67): C 
42.19, H 4.96; found: C 42.28, H 4.95.  
3,4-Di-O-acetyl-2-bromo-2,6-dideoxy-2-fluoro-L-glucopyranose (34): Crystalline 
solid (79 %), anomeric mixture in ratio 4:1, only major isomer described; 1H NMR: d = 
1.22 (d, J = 6.3 Hz, 3H), 2.05 (s, 3H), 2.14 (s, 3H), 3.57 (d, J = 3.4 Hz, 1H), 4.24 (dddd, 
J = 6.3, 6.3, 6.3, 9.7 Hz, 1H), 4.98 (dd, J = 9.7, 9.7 Hz, 1H), 5.50 (d, J = 3.4 Hz, 1H), 
5.58 ppm (dd, J = 9.7 Hz, 3J(F,H) = 9.7 Hz, 1H); 13C NMR: d = 17.2 (CH3), 20.6 
(2 ´ CH3), 66.5 (CH), 71.1 (d, 2J(F,C) = 21.7 Hz, CH), 73.2 (CH), 95.2 (d, 2J(F,C) = 
23.6 Hz, CH), 105.0 (d, 1J(F,C) = 270.2 Hz, C), 169.7 (C), 169.9 ppm (C); 19F NMR: d 
= –119.8 ppm (d, 3J(F,H) = 9.2 Hz, 1F); IR: n~ = 3612, 3490, 2987, 1763, 1430, 1375, 
1232, 1054 cm–1; MS (70 eV, EI): m/z (%): 313/311 (8/8) [M-OH]+, 219 (19), 197/195 
(27/27), 192 (36), 145 (85), 103 (100); HRMS (EI): m/z calcd for C10H1379BrFO5 
[M-OH]+: 310.9930, found: 310.9937; elemental analysis calcd (%) for C10H14BrFO6 
(329.12): C 36.49, H 4.29; found: C 36.67, H 4.30.  
3,4-Di-O-acetyl-2,6-dideoxy-2-fluoro-2-iodo-L-glucopyranose (35): Oil (74 %), 
anomeric mixture in ratio 3:2, major isomer: 1H NMR (500 MHz): d = 1.20 (d, J = 6.3 
Hz, 3H), 2.04 (s, 3H), 2.13 (s, 3H), 4.23 (dddd, J = 6.3, 6.3, 6.3, 9.2 Hz, 1H), 4.93 (dd, J 
= 9.2, 9.5 Hz, 1H), 4.95 (dd, J = 9.5 Hz, 3J(F,H) = 9.5 Hz, 1H), 5.68 ppm (s, 1H); 13C 
NMR (125.7 MHz): d = 17.4 (CH3), 20.6 (CH3), 20.8 (CH3), 71.4 (CH), 71.9 (d, 2J(F,C) 
= 18.8 Hz, CH), 74.0 (CH), 90.8 (d, 1J(F,C) = 270.2 Hz, C), 97.2 (d, 2J(F,C) = 21.8 Hz, 
CH), 169.8 (C), 169.9 ppm (C); 19F NMR: d = -119.4 ppm (d, 3J(F,H) = 8.3 Hz, 1F); 
minor isomer: 1H NMR (500 MHz): d = 1.24 (d, J = 6.2 Hz, 3H), 2.04 (s, 3H), 2.15 (s, 
3H), 3.67-3.73 (m, 2H), 4.77 (dd, J = 9.5 Hz, 3J(F,H) =11.6 Hz, 1H), 4.91 ppm (dd, J = 
9.5, 9.5 Hz, 1H); 13C NMR (125.7 MHz): d = 17.4 (CH3), 20.6 (CH3), 20.7 (CH3), 66.4 
(CH), 73.6 (CH), 74.5 (d, 2J(F,C) = 19.0 Hz, CH), 94.5 (d, 2J(F,C) = 23.2 Hz, CH), 
100.1 (d, 1J(F,C) = 269.4 Hz, C), 169.6 (C), 169.7 ppm (C); 19F NMR: d = -119.4 ppm 
(d, 3J(F,H) = 8.3 Hz, 1F); IR: n~ = 3610, 3476, 2988, 2941, 1762, 1429, 1376, 1235, 
1061 cm–1; MS (70 eV, EI): m/z (%): 376 (1) [M]+, 359 (2), 243 (17), 229 (28), 189 
(38), 147 (45), 127 (100); HRMS (EI): m/z calcd for C10H14FIO6 [M]+: 375.9819, found: 
375.9830; elemental analysis calcd (%) for C10H14FIO6 (376.12): C 31.93, H 3.75; 
found: C 31.93, H 3.51. 
3,4-Di-O-acetyl-2-deoxy-2,2-difluoro-b-L-erythro-pentopyranose (36): Oil (42 %); 
1H NMR (500 MHz): d = 2.13 (s, 3H), 2.14 (s, 3H), 3.14 (d, J = 5.7 Hz, 1H), 3.80 (dd, J 
= 3.8, 12.9 Hz, 1H), 4.23 (dd, J = 2.4, 12.9 Hz, 1H), 5.22 (ddd, J = 4.3 Hz, 3J(F,H) = 
4.3, 4.3 Hz, 1H), 5.32 (m, 1H), 5.53 ppm (dd, J = 3.8, 3J(F,H) = 24.8 Hz, 1H); 13C NMR 
(125.7 MHz): d = 20.4 (CH3), 20.7 (CH3), 60.7 (CH2), 65.8 (dd, 2J(F,C) = 21.4, 21.4 
Hz, CH), 67.7 (CH), 91.8 (dd, 2J(F,C) = 30.5, 30.5 Hz, CH), 114.1 (dd, 1J(F,C) = 253.3, 
253.3 Hz, C), 169.7 (C), 170.5 ppm (C); 19F NMR: d = –120.5 (dd, 3J(F,H) = 18.4 Hz, 
2J(F,F) = 252.4 Hz, 1F), –122.2 ppm (br d, 2J(F,F) = 252.4 Hz, 1F); IR: n~ = 3618, 1762, 
1549, 1239, 1216, 1005 cm-1; MS (70 eV, EI): m/z (%): 237 (55) [M–OH]+, 219 (58), 
91 (100); HRMS (EI): m/z calcd for C9H11F2O5 [M–OH]+: 237.0575, found: 237.0575; 
elemental analysis calcd (%) for C9H12F2O6 (254.17): C 42.53, H 4.76; found: C 42.38, 
H 4.98. 
3,4-Di-O-acetyl-2-chloro-2-deoxy-2-fluoro-L-ribopyranose and 3,4-di-O-acetyl-2-
chloro-2-deoxy-2-fluoro-L-arabinopyranose (37): Oil (75 %), mixture of 
diastereoisomers at C-2 in ratio 6:1, only major isomer described; 1H NMR: d = 2.10 (s, 
3H), 2.14 (s, 3H), 3.77 (dd, J = 4.5, 12.8 Hz, 1H), 4.24 (dd, J = 2.9, 12.8 Hz, 1H), 
5.24-5.31 (m, 2H), 5.55 ppm (dd, J = 3.7 Hz, 3J(F,H) = 20.4 Hz, 1H); 13C NMR: d = 
20.3 (CH3), 20.6 (CH3), 61.1 (CH2), 67.5 (CH), 69.6 (d, 2J(F,C) = 17.2 Hz, CH), 93.8 
(d, 2J(F,C) = 31.2 Hz, CH), 107.4 (d, 1J(F,C) = 255.7 Hz, C), 169.5 (C), 170.4 ppm (C); 
19F NMR: d = -125.9 ppm (d, 3J(F,H) = 18.4 Hz, 1F); IR: n~ = 3612, 2977, 1762, 1371, 
1234, 1120, 1072 cm-1; MS (70 eV, EI): m/z (%): 255/253 (2/7) [M–OH]+, 195 (12), 
175 (19), 164 (23), 153/151 (32/100); HRMS (EI): m/z calcd for C9H1135ClFO5 [M–
OH]+: 253.0279, found: 253.0294; elemental analysis calcd (%) for C9H12ClFO6 
(270.64): C 39.94, H 4.48; found: C 39.70, H 4.84. 
3,4-Di-O-acetyl-2-bromo-2-deoxy-2-fluoro-L-ribopyranose and 3,4-di-O-acetyl-2-
bromo-2-deoxy-2-fluoro-L-arabinopyranose (38): Oil (65 %), NMR showed a 
complex mixture of isomers; 19F NMR: d = –118.8 (s, 1F), –124.0 (s, 1F), –124.0 ppm 
(br s, 1F); IR: n~ = 3577, 2938, 1757, 1372, 1234, 1078 cm-1; MS (70 eV, EI): m/z (%): 
317/315 (<1) [M+1]+, 299/297 (8/8), 211/209 (6/6), 197/195 (77/77), 168/166 (40/43), 
129 (100); HRMS (EI): m/z calcd for C9H1379BrFO6 [M+1]+: 314.9879, found: 
314.9879; elemental analysis calcd (%) for C9H12BrFO6 (315.09): C 34.31, H 3.84; 
found: C 34.21, H 3.80. 
3,4-Di-O-acetyl-2-deoxy-2-fluoro-2-iodo-L-ribopyranose (39): Oil (96 %), anomeric 
mixture in ratio 4:1, only major isomer described. 1H NMR (500 MHz): d = 2.04 (s, 
3H), 2.20 (s, 3H), 3.51 (d, J = 8.8 Hz, 1H), 3.81 (dd, J = 9.0, 11.4 Hz, 1H), 4.06 (dd, J = 
4.3, 11.4 Hz, 1H), 5.23 (dd, J = 8.8 Hz, 3J(F,H) = 12.4 Hz, 1H), 5.33 (ddd, J = 3.5, 4.3, 
9.0 Hz, 1H), 5.66 ppm (dd, J = 3.5 Hz, 3J(F,H) = 4.3 Hz, 1H); 13C NMR (125.7 MHz): d 
= 20.6 (CH3), 20.7 (CH3), 61.7 (CH2), 64.8 (CH), 72.3 (d, 2J(F,C) = 30.5 Hz, CH), 88.4 
(d, 1J(F,C) = 259.4 Hz, CH), 96.5 (d, 2J(F,C) = 18.3 Hz, C), 168.7 (C), 169.5 ppm (C); 
19F NMR: d = -119.6 ppm (s, 1F); IR: n~ = 3577, 3468, 1758, 1371, 1230, 1074 cm-1; 
MS (70 eV, EI): m/z (%): 345 (2) [M–OH]+, 302 (10), 254 (100); HRMS (EI): m/z calcd 
for C9H11FIO5 [M–OH]+: 344.9635, found: 344.9625; elemental analysis calcd (%) for 
C9H12FIO6 (362.09): C 29.85, H 3.34; found: C 30.02, H 3.13. 
(5RS)-1,3,4-Tri-O-acetyl-5-chloro-5-deoxy-5-fluoro-2-O-formyl-5-iodo-D-arabinitol 
(41): Oil (67 %), mixture of isomers in ratio 1:1; 1H NMR: d = 2.04 (s, 6H), 2.13 (s, 
3H), 2.14 (s, 3H), 2.17 (s, 3H), 2.18 (s, 3H), 3.88 (dd, J = 7.6, 11.7 Hz, 1H), 3.90 (dd, J 
= 7.6, 11.7 Hz, 1H), 4.31 (dd, J = 5.0, 11.7 Hz, 2H), 5.20 (dd, J = 8.0 Hz, 3J(F,H) = 8.0 
Hz, 1H), 5.48 (dd, J = 8.0 Hz, 3J(F,H) = 5.4 Hz, 1H), 5.52-5.56 (m, 2H), 5.65 (ddd, J = 
0.6, 8.0 Hz, 4J(F,H) = 1.8 Hz, 1H), 5.88 (ddd, J = 1.9, 8.0 Hz, 4J(F,H) = 0.8 Hz, 1H), 
8.00 ppm (s, 2H); 13C NMR (C6D6): d = 19.9 (CH3), 20.0 (3 ´ CH3), 20.2 (CH3), 20.3 
(CH3), 61.7 (2 ´ CH2), 68.0 (CH), 68.1 (CH), 69.4 (CH), 70.5 (CH), 75.9 (d, 2J(F,C) = 
20.4 Hz, CH), 76.1 (d, 2J(F,C) = 23.6 Hz, CH), 78.8 (d, 1J(F,C) = 313.7 Hz, C), 79.5 (d, 
1J(F,C) = 314.8 Hz, C), 159.6 (CH), 159.8 (CH), 168.1 (C), 168.2 (C), 169.8 (2 ´ C), 
169.8 ppm (2 ´ C); 19F NMR: d = –59.8 (s, 1F), –63.5 ppm (d, 3J(F,H) = 9.0 Hz, 1F); 
IR: n~ = 2954, 1763, 1737, 1432, 1197, 1157, 1067 cm–1; MS (70 eV, EI): m/z (%): 
411/409 (<1) [M–OAc]+, 299 (3), 281 (3), 277 (4), 264 (100); HRMS (EI): m/z calcd for 
C10H1235ClFIO6 [M–OAc]+: 408.9351, found: 408.9342; elemental analysis calcd (%) 
for C12H15ClFIO8 (468.60): C 30.77, H 3.23; found: C 30.65, H 3.08. 
(5RS)-1,3,4-Tri-O-acetyl-5-bromo-5-deoxy-5-fluoro-2-O-formyl-5-iodo-D-arabinitol 
(42): Oil (60 %), mixture of isomers in ratio 1:1; 1H NMR: d = 2.049 (s, 3H), 2.050 (s, 
3H), 2.146 (s, 3H), 2.150 (s, 3H), 2.18 (s, 3H), 2.19 (s, 3H), 3.89 (dd, J = 5.3, 11.7 Hz, 
1H), 3.90 (dd, J = 5.2, 11.7 Hz, 1H), 4.32 (dd, J = 5.0, 11.7 Hz, 1H), 4.35 (dd, J = 4.9, 
11.7 Hz, 1H), 5.28 (dd, J = 7.4 Hz, 3J(F,H) = 7.4 Hz, 1H), 5.53 (dd, J = 8.2 Hz, 3J(F,H) 
= 5.8 Hz, 1H), 5.53-5.58 (m, 2H), 5.63 (ddd, J = 2.0, 7.4 Hz, 4J(F,H) = 1.1 Hz, 1H), 
5.67 (ddd, J = 1.9, 8.2 Hz, 4J(F,H) = 0.9 Hz, 1H), 8.010 (s, 1H), 8.012 ppm (s, 1H); 13C 
NMR: d = 20.5 (2 ´ CH3), 20.6 (2 ´ CH3), 20.8 (2 ´ CH3), 61.7 (2 ´ CH2), 62.4 (d, 
1J(F,C) = 321.0 Hz, C), 63.1 (d, 1J(F,C) = 322.0 Hz, C), 67.8 (2 ´ CH), 69.8 (CH), 70.5 
(CH), 76.4 (d, 2J(F,C) = 21.8 Hz, CH), 76.5 (d, 2J(F,C) = 21.4 Hz, CH), 159.8 (2 ´ CH), 
168.3 (C), 168.4 (C), 169.2 (2 ´ C), 170.3 ppm (2 ´ C); 19F NMR: d = –62.6 (br s, 1F), 
–64.7 ppm (d, 3J(F,H) = 9.2 Hz, 1F); IR: n~ = 2955, 1760, 1736, 1550, 1370, 1217, 1196 
cm–1; MS (70 eV, EI): m/z (%): 455/453 (<1) [M–OAc]+, 327/325 (2/2), 291 (8), 277 
(5), 263 (100); HRMS (EI): m/z calcd for C10H1281BrFIO6 [M–OAc]+: 454.8826, found: 
454.8812; elemental analysis calcd (%) for C12H15BrFIO8 (513.05): C 28.09, H 2.95; 
found: C 28.38, H 2.69. 
(5RS)-1,3,4-Tri-O-benzyl-5-bromo-5-deoxy-5-fluoro-2-O-formyl-5-iodo-D-
arabinitol (46): Oil (46 %), mixture of isomers in ratio 1:1; 1H NMR: d = 3.60-3.63 
(m, 4H), 3.87 (dd, J = 5.6 Hz, 3J(F,H) = 8.5 Hz, 1H), 3.91 (dd, J = 5.8 Hz, 3J(F,H) = 7.3 
Hz, 1H) 4.10 (dd, J = 2.6, 5.8 Hz, 1H), 4.15 (dd, J = 2.6, 5.6 Hz, 1H), 4.44 (d, J = 11.9 
Hz, 2H), 4.48 (d, J = 11.9 Hz, 1H), 4.49 (d, J = 11.9 Hz, 1H), 4.56 (d, J = 10.6 Hz, 
2H), 4.72 (1H, d, J = 11.4 Hz, 1H), 4.73 (1H, d, J = 11.0 Hz, 1H), 4.82 (1H, d, J = 11.4 
Hz, 1H), 4.83 (1H, d, J = 11.0 Hz, 1H), 5.02 (1H, d, J = 10.6 Hz, 1H), 5.04 (1H, d, J = 
10.6 Hz, 1H), 5.49 (ddd, J = 2.6, 6.4, 6.4 Hz, 1H), 5.54 (ddd, J = 2.6, 6.4, 6.4 Hz, 1H), 
7.24-7.41 (m, 30H), 7.97 ppm (s, 2H); 13C NMR: d = 67.5 (2 ´ CH2), 69.3 (d, 1J(F,C) = 
325.6 Hz, C), 69.5 (d, 1J(F,C) = 328.8 Hz, C), 71.2 (2 ´ CH), 73.2 (2 ´ CH2), 74.2 
(2 ´ CH2), 75.8 (2 ´ CH2), 77.7 (CH), 77.8 (CH), 87.4 (d, 2J(F,C) = 18.3 Hz, CH), 88.0 
(d, 2J(F,C) = 18.3 Hz, CH), 127.8-128.4 (30 ´ CH), 136.5 (C), 136.6 (C), 137.27 (C), 
137.29 (C), 137.5 (2 ´ C), 160.3 ppm (2 ´ CH); 19F NMR: d = –57.2 (d, 3J(F,H) = 9.2 
Hz, 1F), –59.8 ppm (s, 1F); IR: n~ = 3091, 3067, 3033, 2929, 1731, 1455, 1173 cm–1; 
MS (70 eV, EI): m/z (%): 567/565 (1/1) [M–Bn]+, 461/459 (1/1), 227/225 (1/1), 181 (9), 
91 (100); HRMS (EI): m/z calcd for C20H2079BrFIO5 [M–Bn]+: 564.9523, found: 
564.9547; elemental analysis calcd (%) for C27H27BrFIO5 (657.32): C 49.34, H 4.14; 
found: C 49.35, H 4.02. 
(5RS)-3,4-di-O-acetyl-5-chloro-1,5-dideoxy-5-fluoro-2-O-formyl-5-iodo-L-
arabinitol (49): Crystalline solid (79 %), mixture of isomers in ratio 1:1; 1H NMR: d = 
0.92 (d, J = 6.5 Hz, 6H), 1.65 (s, 3H), 1.67 (s, 3H), 1.71 (s, 3H), 1.73 (s, 3H), 5.22 
(dddd, J = 1.4, 6.5, 6.5, 6.5 Hz, 1H), 5.23 (dddd, J = 2.0, 6.5, 6.5, 6.5 Hz, 1H), 5.39 (dd, 
J = 8.4 Hz, 3J(F,H) = 6.9 Hz, 1H), 5.51 (ddd, J = 2.0, 8.4 Hz, 4J(F,H) = 0.7 Hz, 1H), 
5.54 (ddd, J = 1.4, 8.6 Hz, 4J(F,H) = 0.7 Hz, 1H), 5.67 (dd, J = 8.6 Hz, 3J(F,H) = 5.1 
Hz, 1H), 7.49 ppm (s, 2H); 13C NMR (C6D6): d = 16.2 (2 ´ CH3), 20.17 (CH3), 20.18 
(CH3), 20.25 (CH3), 20.3 (CH3), 67.4 (2 ´ CH), 72.1 (CH), 73.3 (CH), 76.2 (d, 2J(F,C) 
= 22.8 Hz, CH), 76.4 (d, 2J(F,C) = 26.6 Hz, CH), 79.4 (d, 1J(F,C) = 316.7 Hz, C), 80.0 
(d, 1J(F,C) = 316.7 Hz, C), 159.8 (2 ´ CH), 168.0 (C), 168.1 (C),169.9 ppm (2 ´ C); 19F 
NMR: d = –59.4 (s, 1F), –63.2 ppm (d, 3J(F,H) = 8.3 Hz, 1F); IR: n~ = 2991, 2940, 
1760, 1730, 1371, 1199, 1171, 1069, 1050 cm–1; MS (70 eV, EI): m/z (%): 367/365 (<1) 
[M–OCOH]+, 249 (3), 243/241 (1/3), 205 (100); HRMS (EI): m/z calcd for 
C9H1235ClFIO4 [M–OCOH]+: 364.9453, found: 364.9455; elemental analysis calcd (%) 
for C10H13ClFIO6 (410.57): C 29.25, H 3.19; found: C 29.13, H 3.14.  
(5RS)-3,4-Di-O-acetyl-5-bromo-1,5-dideoxy-5-fluoro-2-O-formyl-5-iodo-L-
arabinitol (50): Crystalline solid (72 %), mixture of isomers in ratio 1:1; 1H NMR: d = 
1.22 (d, J = 6.6 Hz, 3H), 1.23 (d, J = 6.6 Hz, 3H), 2.16 (s, 3H), 2.17 (s, 6H), 2.18 (s, 
3H), 5.42 (dd, J = 8.2 Hz, 3J(F,H) = 6.5 Hz, 1H), 5.33 (dddd, J = 1.0, 6.6, 6.6, 6.6 Hz, 
2H), 5.27 (ddd, J = 1.0, 8.2 Hz, 4J(F,H) = 2.0 Hz, 1H), 5.47 (ddd, J = 1.0, 8.3 Hz, 
4J(F,H) = 1.8 Hz, 1H), 5.53 (dd, J = 8.3 Hz, 3J(F,H) = 5.2 Hz, 1H), 7.96 ppm (s, 2H); 
13C NMR: d = 16.3 (2 ´ CH3), 20.8 (2 ´ CH3), 20.9 (2 ´ CH3), 63.1 (d, 1J(F,C) = 321.4 
Hz, C), 63.8 (d, 1J(F,C) = 323.0 Hz, C), 67.4 (CH), 67.5 (CH), 72.7 (CH), 73.6 (CH), 
76.2 (d, 2J(F,C) = 20.6 Hz, CH), 76.5 (d, 2J(F,C) = 21.3 Hz, CH), 160.0 (2 ´ CH), 168.2 
(C), 168.3 (C), 169.4 ppm (2 ´ C); 19F NMR: d = –62.0 (br s, 1F), –64.3 ppm (d, 
3J(F,H) = 9.2 Hz, 1F); IR: n~ = 2938, 1760, 1730, 1370, 1198, 1171, 1068 cm–1; MS (70 
eV, EI): m/z (%): 411/409 (20/20) [M–OCOH]+, 397/395 (17/17), 369/367 (4/4), 287 
(11), 205 (100); HRMS (EI): m/z calcd for C9H1279BrFIO4 [M–OCOH]+: 408.8948, 
found: 408.8932; elemental analysis calcd (%) for C10H13BrFIO6 (455.02): C 26.40, H 
2.88; found: C 26.53, H 2.80. 
(1RS)-2,3,5-tri-O-acetyl-1-chloro-1-deoxy-1-fluoro-4-O-formyl-1-iodo-D-arabinitol 
(57): Oil (60 %), mixture of diastereoisomers in ratio 1:1; 1H NMR: d = 2.05 (s, 3H), 
2.06 (s, 3H), 2.08 (s, 3H), 2.11 (s, 3H), 2.22 (s, 3H), 2.24 (s, 3H), 4.14 (dd, J = 5.7, 12.7 
Hz, 2H), 4.26 (dd, J = 4.0, 12.7 Hz, 1H), 4.27 (dd, J = 3.0, 12.7 Hz, 1H), 5.11 (dddd, J 
= 0.9, 2.9, 5.6, 8.5 Hz, 1H), 5.15 (dddd, J = 0.8, 2.9, 5.8, 8.3 Hz, 1H), 5.52 (dd, J = 1.7 
Hz, 3J(F,H) = 18.9 Hz, 1H), 5.55 (dd, J = 1.7 Hz, 3J(F,H) = 21.3 Hz, 1H), 6.01 (dd, J = 
1.7, 8.3 Hz, 1H), 6.04 (dd, J = 1.7, 8.5 Hz, 1H), 8.00 ppm (d, J = 0.8 Hz, 2H); 13C 
NMR (C6D6): d = 19.8 (CH3), 20.08 (CH3), 20.14 (3 ´ CH3), 20.3 (CH3), 61.1 (CH2), 
61.2 (CH2), 65.7 (CH), 67.4 (CH), 68.5 (CH), 68.6 (CH), 76.2 (d, 2J(F,C) = 21.5 Hz, 
CH), 76.7 (d, 1J(F,C) = 315.9 Hz, C), 76.8 (d, 2J(F,C) = 20.4 Hz, CH), 77.0 (d, 1J(F,C) 
= 319.1 Hz, C), 159.2 (2 ´ CH), 168.6 (C), 168.7 (3 ´ C), 169.8 ppm (2 ´ C); 19F NMR: 
d = –62.4 (d, 3J(F,H) = 15.9 Hz, 1F), -64.2 ppm (d, 3J(F,H) = 17.5 Hz, 1F); IR: n~ = 
2951, 1766, 1742, 1371, 1200, 1151, 1047 cm–1; MS (70 eV, EI): m/z (%): 425/423 (<1) 
[M–OCOH]+, 307 (1), 301/299 (2/<1), 283/281 (2/<1), 263 (100); HRMS (EI): m/z 
calcd for C11H1435ClFIO6 [M–OCOH]+: 422.9508, found: 422.9501; elemental analysis 
calcd (%) for C12H15ClFIO8 (468.60): C 30.77, H 3.23; found: C 30.78, H 3.16. 
(1RS)-2,3,5-Tri-O-acetyl-1-bromo-1-deoxy-1-fluoro-4-O-formyl-1-iodo-D-arabinitol 
(58): Oil (71 %), mixture of isomers in 1:1 ratio; 1H NMR: d = 2.05 (s, 3H), 2.06 (s, 
3H), 2.08 (s, 3H), 2.11 (s, 3H), 2.23 (s, 3H), 2.25 (s, 3H), 4.14 (dd, J = 5.2, 12.6 Hz, 
2H), 4.26 (dd, J = 3.3, 12.6 Hz, 1H), 4.27 (dd, J = 3.3, 12.6 Hz, 1H), 5.10 (ddd, J = 3.3, 
5.2, 8.2 Hz, 1H), 5.14 (ddd, J = 3.3, 5.2, 8.3 Hz, 1H), 5.55 (dd, J = 1.7 Hz, 3J(F,H) = 
16.4 Hz, 1H), 5.58 (dd, J = 1.4 Hz, 3J(F,H) = 18.0 Hz, 1H), 6.07 (dd, J = 1.7, 8.2 Hz, 
1H), 6.11 (dd, J = 1.4, 8.3 Hz, 1H), 8.01 (s, 1H), 8.02 ppm (s, 1H); 13C NMR: d = 20.5 
(2 ´ CH3), 20.6 (2 ´ CH3), 20.8 (2 ´ CH3), 60.4 (d, 1J(F,C) = 324.3 Hz, C), 60.6 (d, 
1J(F,C) = 327.0 Hz, C), 61.0 (2 ´ CH2), 65.9 (CH), 67.3 (CH), 68.4 (CH), 68.5 (CH), 
76.3 (d, 2J(F,C) = 20.4 Hz, CH), 76.6 (d, 2J(F,C) = 20.2 Hz, CH), 159.8 (2 ´ CH), 168.8 
(2 ´ C), 168.9 (2 ´ C), 170.4 ppm (2 ´ C); 19F NMR: d = –64.4 (d, 3J(F,H) = 18.3 Hz, 
1F), –65.8 ppm (d, 3J(F,H) = 18.3 Hz, 1F); IR: n~ = 2945, 1767, 1740, 1371, 1199, 1152 
cm–1; MS (70 eV, EI): m/z (%): 469/467 (1/1) [M–OCOH]+, 455/453 (1/1), 327/325 
(1/1), 263 (100); HRMS (EI): m/z calcd for C11H1479BrFIO6 [M–OCOH]+: 466.9003, 
found: 466.9000; elemental analysis calcd (%) for C12H15BrFIO8 (513.05): C 28.09, H 
2.95; found: C 28.09, H 2.81. 
(5RS)-3,4-di-O-acetyl-5-chloro-1,5-dideoxy-5-fluoro-2-O-formyl-5-iodo-L-
arabinitol (61): Oil (70 %), mixture of isomers in ratio 1:1; 1H NMR (500 MHz): d = 
1.28 (d, J = 6.4 Hz, 3H), 1.29 (d, J = 6.4 Hz, 3H), 2.12 (s, 3H), 2.19 (s, 3H), 2.23 (s, 
3H), 2.26 (s, 3H), 5.02 (dddd, J = 6.4, 6.4, 6.4, 7.4 Hz, 1H), 5.06 (dddd, J = 6.4, 6.4, 
6.4, 7.0 Hz, 1H), 5.55 (dd, J = 2.0 Hz, 3J(F,H) = 14.0 Hz, 1H), 5.59 (dd, J = 1.7 Hz, 
3J(F,H) = 16.5 Hz, 1H), 5.81 (dd, J = 2.0, 7.0 Hz, 1H), 5.83 (dd, J = 1.7, 7.4 Hz, 1H), 
7.99 ppm (s, 2H); 13C NMR (125.7 MHz, C6D6): d = 15.76 (CH3), 15.84 (CH3), 19.8 
(CH3), 20.1 (CH3), 20.2 (CH3), 20.4 (CH3), 67.7 (CH), 67.8 (CH), 69.5 (CH), 70.8 
(CH), 76.2 (d, 2J(F,C) = 21.5 Hz, CH), 76.7 (d, 2J(F,C) = 20.4 Hz, CH), 77.3 (d, 1J(F,C) 
= 314.8 Hz, C), 77.6 (d, 1J(F,C) = 319.1 Hz, C), 159.3 (2 ´ CH), 168.6 (2 ´ C), 168.8 
(C), 168.9 ppm (C); 19F NMR: d = –62.0 (d, 3J(F,H) = 13.9 Hz, 1F), –63.8 ppm (d, 
3J(F,H) = 17.7 Hz, 1F); IR: n~ = 2992, 2941, 1766, 1736, 1372, 1203, 1163, 1052 cm–1; 
MS (70 eV, EI): m/z (%): 367/365 (<1/2) [M–OCOH]+, 339/337 (<1), 219 (7), 205 
(100); HRMS (EI): m/z calcd for C9H1235ClFIO4 [M–OCOH]+: 364.9453, found: 
364.9462; elemental analysis calcd (%) for C10H13ClFIO6 (410.57): C 29.25, H 3.19; 
found: C 29.26, H 3.18. 
(1RS)-2,3-Di-O-acetyl-1-bromo-1,5-dideoxy-1-fluoro-2-O-formyl-1-iodo-L-
arabinitol (62): Oil (80 %), mixture of isomers in ratio 1:1; 1H NMR: d = 1.28 (d, J = 
6.6 Hz, 3H), 1.29 (d, J = 6.5 Hz, 3H), 2.11 (s, 3H), 2.13 (s, 3H), 2.23 (s, 3H), 2.25 (s, 
3H), 5.00 (dddd, J = 6.6, 6.6, 6.6, 6.6 Hz, 1H), 5.04 (dddd, J = 6.5, 6.5, 6.5, 6.5 Hz, 1H), 
5.58 (dd, J = 1.9 Hz, 3J(F,H) = 15.8 Hz, 1H), 5.59 (dd, J = 1.7 Hz, 3J(F,H) = 17.5 Hz, 
1H), 5.86 (dd, J = 1.9, 6.5 Hz, 1H), 5.89 (dd, J = 1.7, 6.6 Hz, 1H), 7.99 ppm (s, 2H); 13C 
NMR (125.7 MHz): d = 15.9 (2 ´ CH3), 20.6 (CH3), 20.8 (2 ´ CH3), 20.9 (CH3), 61.2 
(d, 1J(F,C) = 326.2 Hz, C), 61.3 (d, 1J(F,C) = 328.6 Hz, C), 67.9 (2 ´ CH), 69.5 (CH), 
70.6 (CH), 76.2 (d, 2J(F,C) = 20.7 Hz, CH), 76.5 (d, 2J(F,C) = 20.2 Hz, CH), 159.6 
(2 ´ CH), 168.9 (2 ´ C), 169.4 ppm (2 ´ C); 19F NMR: d = –64.0 (d, 3J(F,H) = 18.4 Hz, 
1F), –65.4 ppm (d, 3J(F,H) = 18.4 Hz, 1F); IR: n~ = 2940, 1765, 1736, 1371, 1203, 1163, 
1052 cm–1; MS (70 eV, EI): m/z (%): 411/409 (1/1) [M–OCOH]+, 341/339 (2/2), 
241/239 (4/4), 219 (17), 205 (100); HRMS (EI): m/z calcd for C9H1279BrFIO4 [M–
OCOH]+: 408.8948, found: 408.8935; elemental analysis calcd (%) for C10H13BrFIO6 
(455.02): C 26.40, H 2.88; found: C 26.24, H 2.82.  
(4RS)-2,3-Di-O-acetyl-4-chloro-4-deoxy-4-fluoro-1-O-formyl-4-iodo-D-erythritol 
(65): Oil (84 %), mixture of isomers in ratio 1:1; 1H NMR (500 MHz): d = 2.08 (s, 3H), 
2.09 (s, 3H), 2.22 (s, 3H), 2.24 (s, 3H), 4.27 (dd, J = 6.2, 12.4 Hz, 1H), 4.29 (dd, J = 
6.9, 12.4 Hz, 1H), 4.51 (dd, J = 2.8, 12.4 Hz, 1H), 4.55 (dd, J = 2.6, 12.4 Hz, 1H), 5.51 
(dd, J = 4.7 Hz, 3J(F,H) = 16.1 Hz, 1H), 5.56 (dd, J = 5.5 Hz, 3J(F,H) = 11.5 Hz, 1H), 
5.64 (ddd, J = 2.8, 5.5, 6.2 Hz, 1H), 5.67 (ddd, J = 2.6, 4.7, 6.9 Hz, 1H), 8.03 ppm (s, 
2H); 13C NMR (C6D6): d = 19.8 (CH3), 19.9 (CH3), 20.1 (CH3), 20.2 (CH3), 60.7 (CH2), 
60.8 (CH2), 69.5 (CH), 70.1 (CH), 76.9 (d, 1J(F,C) = 316.1 Hz, C), 77.2 (d, 1J(F,C) = 
313.8 Hz, C), 77.6 (d, 2J(F,C) = 22.7 Hz, CH), 78.0 (d, 2J(F,C) = 21.3 Hz, CH), 159.7 (2 
´ CH), 168.6 (2 ´ C), 168.7 (C), 169.8 ppm (C); 19F NMR: d = –61.4 (d, 3J(F,H) = 17.2 
Hz, 1F), –63.1 ppm (d, 3J(F,H) = 12.9 Hz, 1F); IR: n~ = 2940, 1763, 1737, 1371, 1226, 
1200, 1169, 1072 cm–1; MS (70 eV, EI): m/z (%): 297/295 (<1) [M–C4H5O3], 271/269 
(<1), 229/227 (1/3), 211/209 (1/3), 191 (100); HRMS (EI): m/z calcd for C5H637ClFIO3 
[M–C4H5O3]: 296.9005, found: 296.9019; elemental analysis calcd (%) for 
C9H11ClFIO6 (396.54): C 27.26, H 2.80; found: C 27.26, H 2.81.  
(4RS)-2,3-Di-O-acetyl-4-bromo-4-deoxy-4-fluoro-1-O-formyl-4-iodo-D-erythritol 
(66): Oil (65 %), mixture of isomers in ratio 1:1; 1H NMR: d = 2.08 (s, 3H), 2.09 (s, 
3H), 2.23 (s, 3H), 2.24 (s, 3H), 4.27 (dd, J = 6.0, 12.4 Hz, 1H), 4.28 (dd, J = 7.4, 12.4 
Hz, 1H), 4.51 (ddd, J = 1.0, 2.7, 12.4 Hz, 1H), 4.54 (ddd, J = 1.0, 2.6, 12.4 Hz, 1H), 
5.55 (dd, J = 4.7 Hz, 3J(F,H) = 16.6 Hz, 1H), 5.60 (dd, J = 5.2 Hz, 3J(F,H) = 13.5 Hz, 
1H), 5.67 (ddd, J = 2.7, 5.2, 6.0 Hz, 1H), 5.71 (ddd, J = 2.6, 4.7, 7.4 Hz, 1H), 8.03 ppm 
(br s, 2H); 13C NMR: d = 20.6 (CH3), 20.69 (CH3), 20.7 (2 ´ H3), 60.1 (d, 1J(F,C) = 
326.4 Hz, C), 60.4 (d, 1J(F,C) = 324.7 Hz, C), 60.8 (d, 4J(F,C) = 2.1 Hz, CH2), 60.9 (d, 
4J(F,C) = 3.2 Hz, CH2), 69.3 (CH), 70.1 (CH), 77.8 (d, 2J(F,C) = 21.3 Hz, CH), 78.1 (d, 
2J(F,C) = 20.0 Hz, CH), 160.1 (2 ´ CH), 168.3 (C), 168.4 (C), 169.4 (C), 169.5 ppm 
(C); 19F NMR: d = –63.6 (d, 3J(F,H) = 13.8 Hz, 1F), –64.5 ppm (d, 3J(F,H) = 18.4 Hz, 
1F); IR: n~ = 2938, 1760, 1737, 1550, 1371, 1226, 1200, 1070 cm–1; MS (70 eV, EI): 
m/z (%): 383/381 (13/13) [M–OAc]+, 273 (32), 253 (7), 191 (100); HRMS (EI): m/z 
calcd for C7H881BrFIO4 [M–OAc]+: 382.8614, found: 382.8607; elemental analysis 
calcd (%) for C9H11BrFIO6 (440.99): C 24.51, H 2.51; found: C 24.70, H 2.45.  
1,3,4-Tri-O-acetyl-5-deoxy-5,5-difluoro-2-O-formyl-D-arabinitol (68): TBTH (0.10 
mL, 0.37 mmol, 5 equiv) and AIBN (5 mg, 0.03 mmol, 0.4 equiv) were added to a 
solution of difluoro derivative 40 (33 mg, 0.073 mmol, 1 equiv) in dry benzene (2 mL). 
The reaction was refluxing for 30 minutes and then, the solvent was removed under 
vacuum. The residue was purified by column chromatography (hexanes and gradient 
elution to 20 % ethyl acetate) to yield 68 (21 mg, 0.064 mmol, 87 %) as an oil; [a]D = 
+54.7 (c = 0.27); 1H NMR: d = 2.07 (s, 3H), 2.12 (s, 3H), 2.15 (s, 3H), 4.03 (dd, J = 6.8, 
11.9 Hz, 1H), 4.31 (dd, J = 4.7, 11.9 Hz, 1H), 5.20–5.28 (m, 1H), 5.50–5.56 (m, 2H), 
5.84 (dt, J = 3.5 Hz; 2J(F,H) = 54.4 Hz, 1H), 8.05 ppm (s, 1H); 13C NMR: d = 20.4 (2 ´ 
CH3), 20.5 (CH3), 61.5 (CH2), 67.2 (CH), 67.3 (CH), 67.6 (dd, 2J(F,C) = 23.8, 24.8 Hz, 
CH), 112.7 (dd, 1J(F,C) = 243.6, 245.4 Hz, CH), 159.6 (CH), 169.0 (C), 169.3 (C), 
170.3 ppm (C); 19F NMR: d = –128.5 (ddd, 3J(F,H) = 13.8, 55.1 Hz, 2J(F,F) = 293.7 Hz, 
1F), –130.1 (ddd, 3J(F,H) = 9.2, 55.1 Hz, 2J(F,F) = 293.7 Hz, 1F); IR: n~ = 2944, 1761, 
1737, 1371, 1206, 1157 cm–1; MS (70 eV, EI): m/z (%): 327 (1) [M+1]+, 281 (2), 267 
(13), 253 (6), 203 (82), 178 (58), 131 (69), 115 (100); HRMS (EI): m/z calcd for 
C12H17F2O8 [M+1]+: 327.0891, found: 327.0907; elemental analysis calcd (%) for 
C12H16F2O8 (326.25): C 44.18, H 4.94. Found: C 44.20, H 5.03.  
3,4-Di-O-acetyl-1,5,6,7,8-pentadeoxy-5,5-difluoro-2-O-formyl-L-arabino-oct-7-
enitol (69): ATBT (0.10 mL, 0.30 mmol, 5 equiv) and AIBN (4 mg, 0.02 mmol, 0.4 
equiv) were added to a solution of difluoro derivative 48 (24 mg, 0.061 mmol, 1 equiv) 
in dry benzene (2 mL). The reaction was refluxing for 1 h and then, the solvent was 
removed under vacuum. The residue was purified by column chromatography (hexanes 
and gradient elution to 20 % ethyl acetate) to yield 69 (17 mg, 0.055 mmol, 90 %) as an 
oil; [a]D = +26.6 (c = 0.25); 1H NMR: d = 1.23 (d, J = 6.4 Hz, 3H), 2.09 (s, 3H), 2.13 (s, 
3H), 2.63 (ddd, J = 7.0 Hz; 3J(F,H) = 19.0, 19.0 Hz, 2H), 5.20 (dd, J = 1.5, 17.0 Hz, 
1H), 5.24 (dd, J = 1.5, 10.2 Hz, 1H), 5.29-5.35 (m, 2H), 5.44 (ddd, J = 0.8, 2.7, 8.2 Hz, 
1H), 5.78 (dddd, J = 7.0, 7.0, 10.2, 17.0 Hz, 1H), 7.97 ppm (s, 1H); 13C NMR (125.7 
MHz): d = 16.3 (CH3), 20.6 (2 ´ CH3), 38.4 (t, 2J(F,C) = 25.0 Hz, CH2), 67.3 (CH), 68.9 
(t, 2J(F,C) = 28.0 Hz, CH), 70.1 (CH), 121.0 (t, 1J(F,C) = 246.0 Hz, C), 121.0 (CH2), 
127.6 (CH), 160.0 (CH), 168.9 (C), 169.7 ppm (C); 19F NMR: d = -105.5 (dddd, 
3J(F,H) = 9.2, 18.4, 18.4 Hz, 2J(F,F) = 261.6 Hz, 1F), -107.6 ppm (dddd, 3J(F,H) = 
14.0, 14.0, 14.0 Hz, 2J(F,F) = 261.6 Hz, 1F); IR: n~ = 2935, 1757, 1730, 1370, 1209, 
1173, 1055 cm–1; MS (70 eV, EI): m/z (%): 289 (1) [M–F]+, 262 (7), 248 (14), 193 (33), 
145 (100), 103 (67); HRMS (EI): m/z calcd for C13H18FO6 [M–F]+: 289.1087, found: 
289.1099; elemental analysis calcd (%) for C13H18F2O6 (308.28): C 50.65, H 5.89. 
Found: C 50.51, H 5.89.  
5,6,8-Tri-O-acetyl-4-allyl-1,2,3,4-tetradeoxy-4-fluoro-7-O-formyl-D-lyxo-oct-1-
enitol (70): ATBT (0.27 mL, 0.89 mmol, 5 equiv) and AIBN (6 mg, 0.04 mmol, 0.4 
equiv) were added to a solution of diiodo derivative 43 (50 mg, 0.089 mmol, 1 equiv) in 
dry benzene (3 mL). The reaction was refluxing for 40 minutes and then, the solvent 
was removed under vacuum. The residue was purified by column chromatography 
(hexanes and gradient elution to 20 % ethyl acetate) to yield 70 (30 mg, 0.077 mol, 87 
%) as an oil; [a]D +30.3 (c = 0.67, CHCl3); 1H NMR: d = 2.08 (s, 3H), 2.11 (s, 3H), 
2.13 (s, 3H), 2.46-2.57 (m, 4H), 4.02 (dd, J = 6.6, 11.7 Hz, 1H), 4.28 (dd, J = 4.4, 11.7 
Hz, 1H), 5.11-5.19 (m, 4H), 5.28 (dd, J = 5.7 Hz, 2J(F,H) = 15.7 Hz, 1H), 5.57-5.59 
(m, 4H), 8.05 ppm (s, 1H); 13C NMR: d = 20.6 (CH3), 20.7 (2 ´ CH3), 38.4 (d, 2J(F,C) = 
22.7 Hz, CH2), 39.2 (d, 2J(F,C) = 22.4, CH2), 62.2 (CH2), 68.8 (2 ´ CH), 71.3 (d, 
2J(F,C) = 24.2 Hz, CH), 97.3 (d, 1J(F,C) = 180.7 Hz, C), 119.6 (CH2), 120.2 (CH2), 
130.6 (d, 3J(F,C) = 7.7 Hz, CH), 131.0 (d, 2J(F,C) = 7.1 Hz, CH), 159.8 (CH), 169.4 
(C), 169.8 (C), 170.4 ppm (C); 19F NMR: d = -162.0 ppm (m, 1F); IR: n~ = 3081, 2984, 
2937, 1754, 1736, 1645, 1370, 1213 cm–1; MS (70 eV, EI): m/z (%): 347 (2) [M–C3H5]+, 
329 (3), 308 (1), 275 (3), 245 (2), 173 (34), 160 (100), 142 (61); HRMS (EI): m/z calcd 
for C15H20FO8 [M–C3H5]+: 347.1142, found: 347.1114; elemental analysis calcd (%) for 
C18H25FO8 (388.39): C 55.67, H 6.49, found: C 55.73, H 6.36. 
(1S)-1-(1,2,4-Tri-O-acetyl-3-O-formyl-D-threitol-1-C-yl)-1-fluoro-3-cyclopentene 
(71): Grubbs 1st generation catalyst [(PCy3)2Cl2Ru=CHPh] (5 mg) was added, under 
nitrogen, to a solution of 70 (20 mg, 0.05 mmol, 1 equiv) in dry DCM (2 mL) and the 
reaction was stirred at room temperature for 1 h, poured into a saturated NaHCO3 
solution and extracted with DCM. The organic phase was dried over anhydrous Na2SO4 
and concentrated under vacuum. The residue was purified by column chromatography 
(n-hexane/EtOAc, 80.20) to yield 71 (17.5 mg, 0.049 mmol, 94 %) as a white solid; mp 
76.2-77.5 ºC (from n-hexane:ethyl acetate); [a]D = +20.1 (c = 0.33); 1H NMR: d = 2.08 
(s, 3H), 2.10 (s, 3H), 2.15 (s, 3H), 2.44-2.73 (m, 4H), 3.98 (dd, J = 7.2, 11.8 Hz, 1H), 
4.31 (dd, J = 4.6, 11.8 Hz, 1H), 5.33 (dd, J = 7.4 Hz, 3J(F,H) = 19.1 Hz, 1H), 5.55 
(dddd, J = 1.0, 2.8, 4.6, 7.2 Hz, 1H), 5.61 (dd, J = 2.8, 7.4 Hz, 4J(F,H) = 0.8 Hz, 1H), 
5.68 (s, 2H), 8.03 ppm (d, J = 1.0 Hz, 1H); 13C NMR: d = 20.6 (CH3), 20.7 (CH3), 20.8 
(CH3), 42.4 (d, 2J(F,C) = 23.6 Hz, CH2), 42.7 (d, 2J(F,C) = 22.8Hz, CH2), 62.2 (CH2), 
68.5 (d, 4J(F,C) = 2.8 Hz, CH), 68.9 (d, 2J(F,C) = 2.5 Hz, CH), 71.9 (d, 2J(F,C) = 24.6 
Hz, CH), 103.8 (d, 1J(F,C) = 184.9 Hz, C), 127.4 (2 ´ CH), 159.9 (CH), 169.5 (C), 
169.9 (C), 170.4 ppm (C); 19F NMR: d = -152.6 ppm (m, 1F); IR: n~ = 3072, 2937, 
1756, 1370, 1214, 1162, 1039 cm–1.; MS (70 eV, EI): m/z (%): 315 (1) [M–OCOH]+, 
301 (2), 280 (1), 178 (57), 132 (78), 95 (100); HRMS (EI): m/z calcd for C15H20FO6 
[M–OCOH]+: 315.1244, found: 315.1250; elemental analysis calcd (%) for C16H21FO8 
(360.33): C 53.33, H 5.87, found: C 53.36, H 6.07. 
